Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
Open accessAbstract
BACKGROUND: Monitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016. This assessment includes evaluation of the expected epidemiological transition with changes in development and where local patterns deviate from these trends. METHODS: We estimated cause-specific deaths and years of life lost (YLLs) by age, sex, geography, and year. YLLs were calculated from the sum of each death multiplied by the standard life expectancy at each age. We used the GBD cause of death database composed of: vital registration (VR) data corrected for under-registration and garbage coding; national and subnational verbal autopsy (VA) studies corrected for garbage coding; and other sources including surveys and surveillance systems for specific causes such as maternal mortality. To facilitate assessment of quality, we reported on the fraction of deaths assigned to GBD Level 1 or Level 2 causes that cannot be underlying causes of death (major garbage codes) by location and year. Based on completeness, garbage coding, cause list detail, and time periods covered, we provided an overall data quality rating for each location with scores ranging from 0 stars (worst) to 5 stars (best). We used robust statistical methods including the Cause of Death Ensemble model (CODEm) to generate estimates for each location, year, age, and sex. We assessed observed and expected levels and trends of cause-specific deaths in relation to the Socio-demographic Index (SDI), a summary indicator derived from measures of average income per capita, educational attainment, and total fertility, with locations grouped into quintiles by SDI. Relative to GBD 2015, we expanded the GBD cause hierarchy by 18 causes of death for GBD 2016. FINDINGS: The quality of available data varied by location. Data quality in 25 countries rated in the highest category (5 stars), while 48, 30, 21, and 44 countries were rated at each of the succeeding data quality levels. Vital registration or verbal autopsy data were not available in 27 countries, resulting in the assignment of a zero value for data quality. Deaths from non-communicable diseases (NCDs) represented 72·3% (95% uncertainty interval [UI] 71·2-73·2) of deaths in 2016 with 19·3% (18·5-20·4) of deaths in that year occurring from communicable, maternal, neonatal, and nutritional (CMNN) diseases and a further 8·43% (8·00-8·67) from injuries. Although age-standardised rates of death from NCDs decreased globally between 2006 and 2016, total numbers of these deaths increased; both numbers and age-standardised rates of death from CMNN causes decreased in the decade 2006-16-age-standardised rates of deaths from injuries decreased but total numbers varied little. In 2016, the three leading global causes of death in children under-5 were lower respiratory infections, neonatal preterm birth complications, and neonatal encephalopathy due to birth asphyxia and trauma, combined resulting in 1·80 million deaths (95% UI 1·59 million to 1·89 million). Between 1990 and 2016, a profound shift toward deaths at older ages occurred with a 178% (95% UI 176-181) increase in deaths in ages 90-94 years and a 210% (208-212) increase in deaths older than age 95 years. The ten leading causes by rates of age-standardised YLL significantly decreased from 2006 to 2016 (median annualised rate of change was a decrease of 2·89%); the median annualised rate of change for all other causes was lower (a decrease of 1·59%) during the same interval. Globally, the five leading causes of total YLLs in 2016 were cardiovascular diseases; diarrhoea, lower respiratory infections, and other common infectious diseases; neoplasms; neonatal disorders; and HIV/AIDS and tuberculosis. At a finer level of disaggregation within cause groupings, the ten leading causes of total YLLs in 2016 were ischaemic heart disease, cerebrovascular disease, lower respiratory infections, diarrhoeal diseases, road injuries, malaria, neonatal preterm birth complications, HIV/AIDS, chronic obstructive pulmonary disease, and neonatal encephalopathy due to birth asphyxia and trauma. Ischaemic heart disease was the leading cause of total YLLs in 113 countries for men and 97 countries for women. Comparisons of observed levels of YLLs by countries, relative to the level of YLLs expected on the basis of SDI alone, highlighted distinct regional patterns including the greater than expected level of YLLs from malaria and from HIV/AIDS across sub-Saharan Africa; diabetes mellitus, especially in Oceania; interpersonal violence, notably within Latin America and the Caribbean; and cardiomyopathy and myocarditis, particularly in eastern and central Europe. The level of YLLs from ischaemic heart disease was less than expected in 117 of 195 locations. Other leading
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 34 cited sources checked · 0 supported · 0 flagged
- Findingown data
Malaria total deaths decreased 25.9% from 2006 to 2016.
“Other communicable diseases that decreased in terms of total deaths included malaria, measles, leishmaniasis, and intestinal infectious diseases, which decreased by 25·9% (95% UI 6·13–41·4), 72·5% (67·8–77·0), 54·1% (49·8–57·9), and 14·7% (8·87–22·0), respectively, from 2006 to 2016.”
Quote in the paperNot a substantial claim - Findingown data
Total diarrhoeal disease deaths decreased 24.2% from 2.18 million in 2006 to 1.66 million in 2016.
“total deaths decreased by 24·2% (95% UI 14·2–32·2) from 2·18 million deaths (1·72 million to 3·01 million) in 2006 to 1·66 million deaths (1·24 million to 2·37 million) in 2016”
Quote in the paperNot a substantial claim - Findingown data
Years of life lost from ischaemic heart disease were lower than expected in 117 of 195 locations.
“The level of YLLs from ischaemic heart disease was less than expected in 117 of 195 locations.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
In 2016, the ten leading causes of total years of life lost at a finer level of disaggregation were ischaemic heart disease, cerebrovascular disease, lower respiratory infections, diarrhoeal diseases, road injuries, malaria, neonatal preterm birth complications, HIV/AIDS, chronic obstructive pulmonary disease, and neonatal encephalopathy due to birth asphyxia and trauma.
“At a finer level of disaggregation within cause groupings, the ten leading causes of total YLLs in 2016 were ischaemic heart disease, cerebrovascular disease, lower respiratory infections, diarrhoeal diseases, road injuries, malaria, neonatal preterm birth complications, HIV/AIDS, chronic obstructive pulmonary disease, and neonatal encephalopathy due to birth asphyxia and trauma.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
Twenty-seven countries had no verbal autopsy or vital registration data over 1980-2016 and were assigned 0 stars.
“A rating of 0 stars was assigned to 27 countries where no VA or VR data were available over the period from 1980 to2016.”
Quote in the paperNot a substantial claim
- Findingown data
In 2016, the five leading causes of total years of life lost worldwide were cardiovascular diseases; diarrhoea, lower respiratory infections, and other common infectious diseases; neoplasms; neonatal disorders; and HIV/AIDS and tuberculosis.
“Globally, the five leading causes of total YLLs in 2016 were cardiovascular diseases; diarrhoea, lower respiratory infections, and other common infectious diseases; neoplasms; neonatal disorders; and HIV/AIDS and tuberculosis.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
From 2006 to 2016, the total number of deaths from non-communicable diseases rose by 16.1% (95% UI 14.2-18.0), an increase of 5.47 million deaths.
“While total NCD deaths increased from 2006 to 2016, rising 16·1% (95% UI 14·2–18·0)—an additional 5·47 million deaths—”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
Global HIV/AIDS mortality peaked in 2005.
“HIV/AIDS mortality peaked in 2005 globally, with declining death rates probably reflecting the successful expansion of ART programmes and programmes focused on the prevention of mother-to-child transmission (PMTCT).”
Quote in the paperNot a substantial claim - Findingown data
In 2016, communicable, maternal, neonatal, and nutritional diseases caused 19.3% (95% UI 18.5-20.4) of deaths worldwide.
“19·3% (18·5–20·4) of deaths in that year occurring from communicable, maternal, neonatal, and nutritional (CMNN) diseases”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
The global age-standardised HIV/AIDS death rate dropped 52.8% from 29.0 per 100 000 in 2006 to 13.7 per 100 000 in 2016.
“This decrease in absolute mortality level was accompanied by a large decrease in the global age-standardised HIV/AIDS death rate, which dropped 52·8% (95% UI 51·0–54·4) from 29·0 deaths (27·6–30·3) per 100 000 in 2006 to 13·7 deaths (13·1–14·3) per 100 000 in 2016.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, injuries caused 8.43% (95% UI 8.00-8.67) of deaths worldwide.
“a further 8·43% (8·00–8·67) from injuries”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
In 2016, the three leading causes of death among children under 5 worldwide were lower respiratory infections, neonatal preterm birth complications, and neonatal encephalopathy due to birth asphyxia and trauma, together causing 1.80 million deaths (95% UI 1.59-1.89 million).
“In 2016, the three leading global causes of death in children under-5 were lower respiratory infections, neonatal preterm birth complications, and neonatal encephalopathy due to birth asphyxia and trauma, combined resulting in 1·80 million deaths (95% UI 1·59 million to 1·89 million).”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
In 2016, non-communicable diseases accounted for 72.3% (95% UI 71.2-73.2) of deaths worldwide.
“Deaths from non-communicable diseases (NCDs) represented 72·3% (95% uncertainty interval [UI] 71·2–73·2) of deaths in 2016”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
The fraction of deaths assigned to major garbage codes varies widely, even across high-SDI countries.
“The fraction of deaths assigned to major garbage codes varies widely, even across high SDI countries.”
Quote in the paperSubstantial claim - Findingown data
Ischaemic heart disease was the leading cause of total years of life lost in 113 countries for men and 97 countries for women.
“Ischaemic heart disease was the leading cause of total YLLs in 113 countries for men and 97 countries for women.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
Between 1990 and 2016, global deaths from cardiovascular diseases among people older than 70 increased by 53.7% (95% UI 49.3-57.8) to 11.1 million (10.9-11.4 million).
“Between 1990 and 2016, the global number of deaths from cardiovascular diseases for people aged older than 70 years increased by 53·7% (95% UI 49·3–57·8) to 11·1 million deaths (10·9 million to 11·4 million).”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
Between 1990 and 2016, deaths from neoplasms among people aged 70 years and older increased by 86.3% (95% UI 81.0-90.5) to 3.93 million (3.85-4.01 million) in 2016.
“Notably, deaths from neoplasms also increased for older ages, rising 86·3% (95% UI 81·0–90·5) to 3·93 million deaths (3·85 million to 4·01 million) for age 70 years and older in 2016.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Findingown data
Drug-susceptible tuberculosis made up 91.2% of overall tuberculosis deaths.
“Among subcauses of tuberculosis, drug-susceptible tuberculosis deaths composed the largest portion (91·2% [95% UI 90·9–91·6]) of overall tuberculosis deaths; the fastest decrease from 2006 to 2016 occurred for deaths from multidrug-resistant tuberculosis (28·9% [21·5–35·6]).”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised diarrhoeal disease death rates dropped 35.9% from 39.2 per 100 000 in 2006 to 25.1 per 100 000 in 2016.
“while age-standardised rates dropped by 35·9% (27·2–42·4) from 39·2 deaths per 100 000 (30·1 to 55·0) in 2006 to 25·1 deaths (18·8–36·0) per 100 000 in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Multidrug-resistant tuberculosis deaths had the fastest decrease from 2006 to 2016, falling 28.9%.
“Among subcauses of tuberculosis, drug-susceptible tuberculosis deaths composed the largest portion (91·2% [95% UI 90·9–91·6]) of overall tuberculosis deaths; the fastest decrease from 2006 to 2016 occurred for deaths from multidrug-resistant tuberculosis (28·9% [21·5–35·6]).”
Quote in the paperNot a substantial claim - Findingown data
Global HIV/AIDS deaths fell 45.8% from 1.91 million in 2006 to 1.03 million in 2016.
“Overall, HIV/AIDS deaths decreased by 45·8% (95% UI 43·7–47·7) from 1·91 million deaths (1·81–2·00) in 2006 to 1·03 million deaths (987 000 to 1·08 million) in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Among post-neonates in 2016, half of deaths were caused by lower respiratory infections, diarrhoeal diseases, and malaria.
“Among post-neonates, half of deaths in 2016 were caused by lower respiratory infections (22·7% [95% UI 20·7–25·3], 338 000 deaths [306 000–377 000]), diarrhoeal diseases (15·5% [13·7–17·5], 231 000 deaths [202 000–263 000]), and malaria (11·3% [8·35–14·53], 167 000 deaths [123 000–217 000]).”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised rates for unintentional injuries decreased 16.1% from 31.4 per 100 000 in 2006 to 26.3 per 100 000 in 2016.
“Age-standardised rates for unintentional injuries overall decreased 16·1% (13·6–18·6) from 2006 to 2016 from 31·4 deaths (27·6–32·7) per 100 000 to 26·3 deaths (23·1–27·6) per 100 000.”
Quote in the paperNot a substantial claim - Findingown data
Global age-standardised death rates fell across all injuries by 14.4% from 75.3 per 100 000 in 2006 to 64.4 per 100 000 in 2016.
“Although global age-standardised death rates fell across all injuries by 14·4% (95% UI 12·0–16·5) from 75·3 deaths (71·0–77·3) per 100 000 in 2006 to 64·4 deaths (60·7–66·6) per 100 000 in 2016, total injury deaths were largely unchanged from levels in 2006 (table 2).”
Quote in the paperNot a substantial claim - Findingown data
Neonatal disorder age-standardised death rates decreased 25.0% from 33.6 per 100 000 in 2006 to 25.2 per 100 000 in 2016.
“and by 25·0% (21·0–29·0) for age-standardised death rates (33·6 deaths [32·4–35·1] per 100 000 in 2006 to 25·2 deaths [23·9–26·5] per 100 000 in 2016).”
Quote in the paperNot a substantial claim - Findingown data
From 1980 to 1988, conflict and terrorism resulted in 2.28 million deaths worldwide.
“From 1980 to 1988, conflict and terrorism resulted in 2·28 million deaths (95% UI 1·55 million to 3·11 million) worldwide (figure 4A).”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised death rates fell globally from 2006 to 2016 for alcoholic cardiomyopathy, digestive congenital anomalies, and congenital musculoskeletal and limb anomalies.
“Among NCD causes included in the expansion of the GBD cause hierarchy for GBD 2016, age-standardised death rates fell globally between 2006 and 2016 for alcoholic cardiomyopathy, digestive congenital anomalies, and congenital musculoskeletal and limb anomalies, by 24·0% (95% UI 7·52–36·8), 19·0% (3·73–31·3), and 18·2% (1·11–31·4), respectively”
Quote in the paperNot a substantial claim - Findingown data
Neonatal deaths composed 43.3% of total under-5 deaths in 2016.
“Deaths in neonates (0–27 days of age) composed the largest proportion, 43·3% (95% UI 42·7–43·8), of total under-5 deaths in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Protein-energy malnutrition caused the largest number of nutritional deficiency deaths, 308 000 in 2016.
“Protein-energy malnutrition caused the largest number of deaths for nutritional deficiencies with 308 000 deaths (95% UI 277 000–356 000) in 2016, followed by other nutritional deficiencies, which caused 54 500 deaths (46 000–65 000).”
Quote in the paperNot a substantial claim - Findingown data
Neonatal lower respiratory infection deaths decreased 44.5% from 278 000 in 2006 to 154 000 in 2016.
“then by lower respiratory infections, which decreased 44·5% (38·9–49·6) from 278 000 deaths (245 000–305 000) to 154 000 deaths (133 000–172 000).”
Quote in the paperNot a substantial claim - Findingown data
Total maternal disorder deaths decreased 23.6% from 2006 to 2016.
“Total deaths from maternal disorders decreased by 23·6% (95% UI 16·7–29·3), while age-standardised death rates across maternal disorders decreased by 30·5% (24·2–35·7) to 3·0 (2·8–3·3) per 100 000 in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Neonatal tetanus deaths decreased 67.6% from 46 300 in 2006 to 15 000 in 2016.
“The largest percent change for neonates was in deaths due to tetanus, which decreased 67·6% (95% UI 57·9–75·3) from 46 300 deaths (24 000–62 100) in 2006 to 15 000 deaths (8330–20 400) in 2016”
Quote in the paperNot a substantial claim - Findingown data
The recent increase in global conflict and terrorism deaths from 2011 to 2016 was dominated by mortality in North Africa and the Middle East.
“The recent increase in global deaths from conflict and terrorism (2011–16) was dominated by mortality in North Africa and the Middle East which ranged from a low of 77·2% (95% UI 63·0–83·9) in 2014 to a high of 90·9% (85·8–94·3) in 2016 of global conflict and terrorism deaths during this time period.”
Quote in the paperNot a substantial claim - Findingown data
Global neoplasm deaths increased 17.8% from 7.58 million in 2006 to 8.93 million in 2016.
“Deaths from neoplasms increased globally by 17·8% (95% UI 15·8–19·9), rising from 7·58 million deaths (7·46 million to 7·67 million) in 2006 to 8·93 million deaths (8·75 million to 9·09 million) in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Cerebrovascular disease age-standardised death rates decreased 21.0% from 110 per 100 000 in 2006 to 86.5 per 100 000 in 2016.
“Declines in age-standardised cardiovascular disease mortality rates were primarily driven by declines in cerebrovascular disease death rates, which decreased 21·0% (95% UI 19·0–22·9) between 2006 and 2016, from an age-standardised death rate of 110 deaths per 100 000 (106–113) in 2006 to 86·5 deaths (83·3–89·9) per 100 000 in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised COPD death rates significantly decreased 21.1% to 46.8 per 100 000 since 2006.
“Since 2006, age-standardised death rates from COPD significantly decreased (21·1% [18·2–23·3]), to 46·8 deaths (45·0–49·8) per 100 000.”
Quote in the paperNot a substantial claim - Findingown data
The overall age-standardised neoplasm death rate fell 9.38% from 147.7 per 100 000 in 2006 to 133.9 per 100 000 in 2016.
“Over the same time period, the overall age-standardised neoplasm death rate fell by 9·38% (7·78–10·8) from 147·7 deaths per 100 000 (145·4 to 149·5) in 2006 to 133·9 deaths (131·3–136·3) per 100 000 in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Global cardiovascular disease deaths increased 14.5% between 2006 and 2016.
“Globally, deaths from cardiovascular disease increased by 14·5% (95% UI 12·1–17·1) between 2006 and 2016, though age-standardised death rates from cardiovascular disease decreased by 14·5% (12·5–16·2) over this same time period.”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised cardiovascular disease death rates decreased 14.5% between 2006 and 2016.
“Globally, deaths from cardiovascular disease increased by 14·5% (95% UI 12·1–17·1) between 2006 and 2016, though age-standardised death rates from cardiovascular disease decreased by 14·5% (12·5–16·2) over this same time period.”
Quote in the paperNot a substantial claim - Findingown data
Leishmaniasis total deaths decreased 54.1% from 2006 to 2016.
“Other communicable diseases that decreased in terms of total deaths included malaria, measles, leishmaniasis, and intestinal infectious diseases, which decreased by 25·9% (95% UI 6·13–41·4), 72·5% (67·8–77·0), 54·1% (49·8–57·9), and 14·7% (8·87–22·0), respectively, from 2006 to 2016.”
Quote in the paperNot a substantial claim - Findingown data
Total injury deaths were largely unchanged from 2006 levels.
“Although global age-standardised death rates fell across all injuries by 14·4% (95% UI 12·0–16·5) from 75·3 deaths (71·0–77·3) per 100 000 in 2006 to 64·4 deaths (60·7–66·6) per 100 000 in 2016, total injury deaths were largely unchanged from levels in 2006 (table 2).”
Quote in the paperNot a substantial claim - Findingown data
Neonatal disorder total deaths decreased 25.3% from 2.32 million in 2006 to 1.73 million in 2016.
“Neonatal disorders decreased by 25·3% (95% UI 21·3–29·3) for total deaths, declining from 2·32 million deaths (2·24 million to 2·42 million) in 2006 to 1·73 million deaths (1·64 million to 1·82 million) in 2016”
Quote in the paperNot a substantial claim - Findingown data
Measles deaths decreased the most among post-neonates and children aged 1-4 years from 2006 to 2016, dropping 72.0% in both groups.
“Deaths from measles decreased the most from 2006 to 2016 among both post-neonates and children aged 1–4 years, dropping by 72·0% (95% UI 66·6–76·5) from 63 100 deaths (23 700 to 140 000) to 17 700 deaths (6470–39 300) and by 72·0% (66·7–76·9) from 147 000 deaths (59 600 to 302 000) to 41 300 (15 700–87 300), respectively.”
Quote in the paperNot a substantial claim - Findingown data
Measles total deaths decreased 72.5% from 2006 to 2016.
“Other communicable diseases that decreased in terms of total deaths included malaria, measles, leishmaniasis, and intestinal infectious diseases, which decreased by 25·9% (95% UI 6·13–41·4), 72·5% (67·8–77·0), 54·1% (49·8–57·9), and 14·7% (8·87–22·0), respectively, from 2006 to 2016.”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised mortality for all nutritional deficiencies decreased 23.7% from 7.26 per 100 000 in 2006 to 5.54 per 100 000 in 2016.
“age-standardised mortality rates for all nutritional deficiencies decreased by 23·7% (95% UI 15·4–30·8) from 7·26 deaths (6·75–7·86) per 100 000 in 2006 to 5·54 deaths (5·04–6·34) per 100 000 in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised rates for interstitial lung disease and pulmonary sarcoidosis increased non-significantly by 5.85% to 2.0 per 100 000.
“but increased, although not significantly, for interstitial lung disease and pulmonary sarcoidosis (5·85% [–4·31 to 13·9], to 2·0 deaths [1·42–2·31] per 100 000).”
Quote in the paperNot a substantial claim - Findingown data
In 1994, deaths in Rwanda dominated the highest single-year death toll from conflict and terrorism worldwide.
“In 1994, deaths in Rwanda (504 000 deaths [95% UI 180 000– 826 000]) dominated the highest single-year death toll from conflict and terrorism worldwide.”
Quote in the paperNot a substantial claim - Findingown data
Dengue age-standardised death rates increased from 0.3 per 100 000 in 2006 to 0.5 per 100 000 in 2016.
“while age-standardised rates increased from 0·3 deaths per 100 000 (0·01–0·4) in 2006 to 0·5 (0·2–0·7) deaths per 100 000 in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Neonatal diarrhoeal disease deaths decreased 58.3% from 88 400 in 2006 to 36 900 in 2016.
“followed by diarrhoeal diseases, which decreased 58·3% (51·8–63·6) from 88 400 deaths (79 200–99 600) to 36 900 deaths (32 700–41 300)”
Quote in the paperNot a substantial claim - Findingown data
Haemolytic disease and other neonatal jaundice caused 36 900 fewer deaths in 2016 than in 2006, a reduction of 42.8%.
“The largest decrease for neonatal disorders was for haemolytic disease and other neonatal jaundice, which caused 36 900 fewer deaths in 2016 than in 2006 (a reduction of 42·8% [95% UI 34·4–50·7]).”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised maternal disorder death rates decreased 30.5% to 3.0 per 100 000 in 2016.
“Total deaths from maternal disorders decreased by 23·6% (95% UI 16·7–29·3), while age-standardised death rates across maternal disorders decreased by 30·5% (24·2–35·7) to 3·0 (2·8–3·3) per 100 000 in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Injuries accounted for 160 000 deaths among children aged 1-4 years in 2016.
“Injuries contributed relatively more to mortality among children aged 1–4 years compared with children younger than 1 year, accounting for 160 000 deaths in 2016 [146 000–175 000].”
Quote in the paperNot a substantial claim - Findingown data
The change in global deaths from other neglected tropical diseases from 2006 to 2016 was not significant, with an estimated increase of 3.06%.
“For several causes, changes from 2006 to 2016 in global numbers of deaths were not significant: Chagas disease (increase of 1·42% [95% UI –4·88 to 9·49), yellow fever (decrease of 11·8% [–25·9 to 6·44]), and other neglected tropical diseases (NTD; an increase of 3·06% [–23·2 to 34·3]).”
Quote in the paperNot a substantial claim - Findingown data
The change in global Chagas disease deaths from 2006 to 2016 was not significant, with an estimated increase of 1.42%.
“For several causes, changes from 2006 to 2016 in global numbers of deaths were not significant: Chagas disease (increase of 1·42% [95% UI –4·88 to 9·49), yellow fever (decrease of 11·8% [–25·9 to 6·44]), and other neglected tropical diseases (NTD; an increase of 3·06% [–23·2 to 34·3]).”
Quote in the paperNot a substantial claim - Findingown data
Ischaemic heart disease and cerebrovascular disease together accounted for more than 85.1% of all cardiovascular disease deaths in 2016.
“Ischaemic heart disease and cerebrovascular disease (stroke) combined accounted for more than 85·1% of all cardiovascular disease deaths in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised asthma death rates decreased 24.3% to 6.29 per 100 000.
“Age standardised rates for asthma also decreased (24·3% [19·1–30·3] to 6·29 deaths [5·08–7·77] per 100 000)”
Quote in the paperNot a substantial claim - Findingown data
Total ischaemic heart disease deaths rose 19.0% from 7.96 million in 2006 to 9.48 million in 2016.
“Total deaths from ischaemic heart disease rose by 19·0% (16·2–22·1), increasing from 7·96 million deaths (7·81 million to 8·12 million) in 2006 to 9·48 million deaths (9·23 million to 9·76 million) in 2016”
Quote in the paperNot a substantial claim - Findingown data
Two causes had statistically significant positive annualised rates of change in age-standardised YLL rates since 2006: dengue and Parkinson's disease.
“Two causes had statistically significant, positive annualised rates of change in age-standardised YLL rates since 2006: dengue (3·8% [95% UI 1·4–6·4]); and Parkinson’s disease (0·25% [0·054–0·46]).”
Quote in the paperNot a substantial claim - Findingown data
Total global deaths decreased significantly for only one neoplasm from 2006 to 2016: Hodgkin's lymphoma, by 6.24%.
“Total global deaths decreased significantly for only one type of neoplasm from 2006 to 2016: Hodgkin’s lymphoma (decreased 6·24% [95% UI 3·07–9·75]).”
Quote in the paperNot a substantial claim - Findingown data
Intestinal infectious disease total deaths decreased 14.7% from 2006 to 2016.
“Other communicable diseases that decreased in terms of total deaths included malaria, measles, leishmaniasis, and intestinal infectious diseases, which decreased by 25·9% (95% UI 6·13–41·4), 72·5% (67·8–77·0), 54·1% (49·8–57·9), and 14·7% (8·87–22·0), respectively, from 2006 to 2016.”
Quote in the paperNot a substantial claim - Findingown data
The change in global yellow fever deaths from 2006 to 2016 was not significant, with an estimated decrease of 11.8%.
“For several causes, changes from 2006 to 2016 in global numbers of deaths were not significant: Chagas disease (increase of 1·42% [95% UI –4·88 to 9·49), yellow fever (decrease of 11·8% [–25·9 to 6·44]), and other neglected tropical diseases (NTD; an increase of 3·06% [–23·2 to 34·3]).”
Quote in the paperNot a substantial claim - Findingown data
Cerebrovascular disease was the leading cause of YLLs for both sexes in many countries in Southeast and East Asia.
“For both sexes, cerebrovascular disease was the leading cause of YLLs for many countries in Southeast and East Asia.”
Quote in the paperNot a substantial claim - Findingown data
The number of communicable diseases in the leading 30 causes of YLLs in each SDI quintile decreased with increasing SDI.
“The number of communicable diseases in the leading 30 causes of YLLs in each quintile of SDI decreased with increasing SDI, reflecting the ongoing epidemiological transition (figure 7).”
Quote in the paperNot a substantial claim - Findingown data
In 2016, the burden of all-cause YLLs ranged from 6834.9 per 100 000 in Japan to 80115.5 per 100 000 in the Central African Republic.
“In 2016, the burden of all-cause YLLs ranged from an age-standardised rate of 6834·9 (95% UI 6702·8–6974·3) per 100 000 in Japan to 80115·5 (68 631·5–92 475·5) per 100 000 in the Central African Republic”
Quote in the paperNot a substantial claim - Findingown data
At the global level, significant declines from 2006 to 2016 in age-standardised YLL rates occurred for the leading ten causes by number of global YLLs.
“At the global level, significant declines from 2006 to 2016 in age-standardised YLL rates occurred for the leading ten causes by number of global YLLs.”
Quote in the paperSubstantial claim - Findingown data
In North Africa and the Middle East, Saudi Arabia, Bahrain, Kuwait, and Qatar had observed-to-expected ratios of YLLs for ischaemic heart disease below 0.50.
“This was commonly the case in the region of North Africa and the Middle East, where Saudi Arabia, Bahrain, Kuwait, and Qatar in particular had observed-to-expected ratios of YLLs for ischaemic heart disease below 0·50.”
Quote in the paperNot a substantial claim - Findingown data
In India, ischaemic heart disease was the leading cause of YLLs for both men and women.
“In India, ischaemic heart disease was the leading cause for men and women.”
Quote in the paperNot a substantial claim - Findingown data
The greatest total burden of YLLs for CMNN causes in 2016 was in low and low-middle SDI.
“The greatest total burden of YLLs for CMNN causes in 2016 were in low and low-middle SDI, at 204 million (95% UI 193 million to 217 million) and 259 million (246 million to 274 million), respectively.”
Quote in the paperNot a substantial claim - Findingown data
For women, Alzheimer's disease ranked higher than for men in France, Spain, and Japan.
“For women, the general patterns were similar with the exception of a higher ranking for Alzheimer’s disease as compared to men, in France, Spain, and Japan.”
Quote in the paperNot a substantial claim - Findingcitation
The present findings correspond with a GBD 2015 analysis of personal health care access and quality, in which absolute levels of and progress on NCDs amenable to personal health care were greater in higher-SDI locations.
“Our findings here correspond with a GBD 2015 analysis of personal health care access and quality,43 wherein absolute levels of and progress on NCDs amenable to personal health care were greater among higher-SDI locations than those of lower SDI.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Dieleman, 2016, Development assistance for health: past trends, associations, and the future of international financial flows for health, Lancet source
Not checked in the free run.
- Findingown data
Interpersonal violence was the leading cause of YLLs for men in a corridor from Central America through Tropical Latin America.
“Interpersonal violence was the leading cause for men in a corridor that runs from Central America through Tropical Latin America.”
Quote in the paperNot a substantial claim - Findingown data
Age-standardised YLL rates for NCDs were generally higher at lower SDI in each year examined.
“Although not as large as the gradient between SDI quintiles observed for CMNN causes, age-standardised YLL rates for NCDs were generally higher at lower increments of SDI in each year examined.”
Quote in the paperNot a substantial claim - Findingown data
Declines in age-standardised YLL rates for CMNN causes over 37 years ranged from 60.6% in high SDI to 77.0% in high-middle SDI, 74.1% in middle SDI, 69.0% in low-middle SDI, and 58.5% in low SDI.
“Declines in age-standardised YLL rates for CMNN causes over the 37 years examined ranged from 60·6% (95% UI 58·2–64·7) for high SDI locations, 77·0% (73·4–79·9) for high-middle SDI, 74·1% (72·3–76·0) for middle SDI, 69·0% (66·9–70·9) for low-middle SDI, and 58·5% (55·6–61·0) for low SDI.”
Quote in the paperNot a substantial claim - Findingown data
Globally, ischaemic heart disease and cerebrovascular disease were the leading causes of YLLs for both sexes for 123 countries in 2016, including China and India.
“Globally, ischaemic heart disease and cerebrovascular disease were the leading causes of YLLs for both sexes for 123 countries in 2016, including in China (cerebrovascular disease [stroke]) and India (ischaemic heart disease).”
Quote in the paperNot a substantial claim - Findingnone given
The impact of fatal discontinuities was more noticeable in lower-SDI quintiles.
“The impact of these fatal discontinuities was more noticeable in lower-SDI quintiles.”
Quote in the paperNot a substantial claim - Findingcitation
The phenomenon of greater progress on average for larger problems is also seen in each SDI quintile.
“This phenomenon of greater progress on average for larger problems33 is also seen in each SDI quintile.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Leon, 2007, Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study, Lancet source
Not checked in the free run.
- Findingnone given
Since 2006, statistically significant increases in YLL rates occurred for opioid use, amphetamine use, and other drug use disorders in some locations, particularly at high SDI.
“Since 2006, statistically significant increases in YLL rates occurred for opioid use, amphetamine use, and other drug use disorders in some locations—particularly at high-SDI.”
Quote in the paperNot a substantial claim - Findingown data
Of the ten leading causes of YLLs globally in 2016, ischaemic heart disease was the cause for which YLLs were most often lower than expected on the basis of SDI alone, in 117 locations.
“In 2016, of the ten leading causes of YLLs globally, ischaemic heart disease was the cause for which YLLs were most often lower than expected on the basis of SDI alone (in 117 locations globally).”
Quote in the paperNot a substantial claim - Findingown data
Maternal disorders were not the leading cause of YLLs in any location.
“Maternal disorders were not the leading cause of YLLs in any location.”
Quote in the paperNot a substantial claim - Findingown data
Since 1980, annualised rates of decline for NCDs have been faster in high-SDI quintiles than in low-SDI quintiles.
“Since 1980, annualised rates of decline for NCDs have been faster for high-SDI quintiles than low-SDI quintiles—a sharp contrast with the rapid reductions in CMNN diseases achieved by lower-SDI locations.”
Quote in the paperSubstantial claim - Findingown data
For locations in the high-income GBD super-region, cancers, particularly tracheal, bronchus, and lung cancer, ranked within the leading five causes of YLLs in 32 of 34 locations.
“For locations in the high-income GBD super-region, cancers, particularly the cause grouping of tracheal, bronchus, and lung cancer, ranked within the leading five causes of YLLs in 32 of 34 locations.”
Quote in the paperNot a substantial claim - Findingown data
The observation of faster declines for larger initial YLL rates also holds when annualised rates of decline are compared to 2006 age-standardised YLL levels rather than 2016 levels.
“If annualised rates of decline are compared to levels of age-standardised YLLs in 2006 rather than 2016, these observations also hold true.”
Quote in the paperNot a substantial claim - Findingown data
In China, cerebrovascular disease was the leading cause of YLLs for both men and women.
“The leading cause of YLLs in China was cerebrovascular disease for both men and women.”
Quote in the paperNot a substantial claim - Findingown data
Countries where other causes ranked higher were primarily in sub-Saharan Africa, North Africa and the Middle East, and Latin America and the Caribbean.
“Countries where other causes ranked higher were primarily found in three GBD super-regions: sub-Saharan Africa, where HIV/AIDS was the leading cause of YLLs for 16 of 46 locations; North Africa and the Middle East where conflict and terrorism was the leading cause in three of 21 locations; and Latin America and the Caribbean, where either interpersonal violence or lower respiratory infections were”
Quote in the paperNot a substantial claim - Findingown data
Across SDI quintiles, the greatest difference in age-standardised YLL rates in each period was for CMNN causes.
“Across quintiles, the greatest difference between SDI quintiles in YLL age-standardised rates in each time period was for CMNN causes, which ranged from 1875·4 (95% UI 1793·1–2032·5) per 100 000 in high SDI to 51 247·8 (48 640·9–53 887·2) per 100 000 in low SDI in 1980, and in 2016 from 739·0 (707·7–761·7) per 100 000 in high SDI to 21 299·6 (20 220·9–22 549·4) per 100 000 in low SDI.”
Quote in the paperNot a substantial claim - Findingown data
The largest increase in total YLLs was for injuries in low SDI, at 21.2%.
“The largest increase in total YLLs was for injuries in low SDI 21·2% (95% UI 11·7–31·9).”
Quote in the paperNot a substantial claim - Findingown data
For low-middle-SDI and low-SDI quintiles, age-standardised rates decreased from 2006 to 2016 for all causes ranked higher than the tenth leading cause, except ischaemic heart disease at low-middle SDI, for which the increase was non-significant.
“For both low-middle-SDI and low-SDI quintiles, age-standardised rates decreased from 2006 to 2016 for all causes ranked higher than the tenth leading cause (figure 7D, E) with the exception of ischaemic heart disease at low-middle SDI, for which the increase was non-significant.”
Quote in the paperNot a substantial claim - Findingown data
The largest decrease in total YLLs from 1990 to 2016 was for CMNN causes in middle SDI, which decreased 36.9%.
“The largest decrease in total YLLs from 1990 to 2016 was for CMNN causes in middle SDI, which decreased by 36·9% (95% UI 34·7–39·2).”
Quote in the paperNot a substantial claim - Findingown data
Finland, Moldova, New Zealand, and Singapore averaged less than 5% of deaths assigned to major garbage codes since 2010.
“Countries such as Finland, Moldova, New Zealand, Singapore, and that have less than 5% of deaths on average since 2010 assigned to major garbage codes strongly imply that high-quality certification is possible at the national level.”
Quote in the paperNot a substantial claim - Findingreasoning
At the global level, the fraction of registered deaths assigned to major garbage codes declined over the past 37 years.
“At the global level, the fraction of all registered deaths assigned to major garbage codes decreased over the past 37 years, owing to ongoing improvements in data collection and recording.”
Quote in the paperNot a substantial claim - Findingnone given
From 1980 to 2016, cause-specific years of life lost rates fell at an accelerated pace for nearly all causes, even amid threats to health.
“The accelerated declines in cause-specific YLLs rates for nearly all causes is occurring despite threats to human health such as climate change, antimicrobial resistance, obesity, emerging infectious diseases, and conflict.6,50–60”
Quote in the paperSubstantial claim - Findingreasoning
Adding the detailed SRS verbal autopsy data to GBD 2016 substantially altered estimates for multiple causes.
“The inclusion of the detailed SRS VA data in GBD 2016 substantially changed estimates for multiple causes.”
Quote in the paperNot a substantial claim - Findingreasoning
The malaria modifications led to overall declines in predicted malaria deaths in Myanmar and India.
“These modifications led to different changes in different countries, but most notably overall declines in predicted malaria deaths in Myanmar and India.”
Quote in the paperNot a substantial claim - Findingown data
Mortality declines for major non-communicable diseases and injuries are much slower.
“These data also point to the much slower declines in mortality for major NCDs and injuries, suggesting that these conditions, which cause very substantial mortality in young and middle-aged adults, need to receive much greater policy priority given the compelling evidence from some countries that bold public policies to reduce avoidable mortality from these causes are effective.”
Quote in the paperSubstantial claim - Findingown data
GBD 2016 estimated multidrug-resistant and extensively drug-resistant tuberculosis at 8.8% (95% UI 7.4-10.4) of all tuberculosis deaths.
“In addition, for the first time, we have estimated multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis (8·8% [95% UI 7·4–10·4] of all tuberculosis deaths) from the global tuberculosis envelope.”
Quote in the paperNot a substantial claim - Findingnone given
In 2010-16, more countries were reported with 4-star or 5-star data quality ratings.
“In 2010–16, we reported more countries with 4-star or 5-star ratings.”
Quote in the paperNot a substantial claim - Findingreasoning
Changes in MIR modelling and data led to shifts in cancer mortality estimates.
“The changes in MIR modelling as well as the changes in data led to some shifts in cancer mortality.”
Quote in the paperNot a substantial claim - Findingown data
Even in countries with 5-star cause-of-death quality ratings, neonatal cause-of-death patterns vary remarkably.
“Even in countries with 5-star cause of death quality ratings, there is remarkable variation in neonatal cause of death patterns.”
Quote in the paperNot a substantial claim - Findingown data
In those countries with low major garbage coding, even among people older than 80 years major garbage coding remained below 20%.
“Even in the population aged older than 80 years, these countries have kept major garbage coding less than 20%.”
Quote in the paperNot a substantial claim - Interpretationown data
The global shift toward deaths at older ages suggests success in reducing many causes of early death.
“A global shift towards deaths at older ages suggests success in reducing many causes of early death.”
Quote in the paperSubstantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
- Study design and conductnone given
The study could not incorporate uncertainty from garbage code redistribution algorithms into final estimates.
“We remain unable to incorporate uncertainty from garbage code redistribution algorithms into our final estimates.”
Quote in the paperNot a substantial claim - Study design and conductown data
Uncertainty intervals were derived from 1000 draws from posterior distributions and propagated into final quantities of interest.
“We determined UIs for components of cause-specific estimation based on 1000 draws from the posterior distribution of cause-specific mortality by age, sex, and location for each year included in the GBD 2016 analysis. In this way, uncertainty could be quantified and propagated into the final quantities of interest.”
Quote in the paperSubstantial claim - Study design and conductreasoning
Data from countries without extensive vital registration coverage were excluded from models for countries with such coverage to avoid inflating uncertainty.
“data from countries without extensive VR coverage were excluded from models for countries with this coverage to avoid inflation of uncertainty.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The absence of a parallel increase in age-specific prevalence supports the view that increases in death rates for Alzheimer's disease and other dementias, Parkinson's disease, and atrial fibrillation and flutter are reporting artefacts rather than true epidemiological changes.
“The absence of a parallel increase of the same magnitude in reported rates of age-specific prevalence of these diseases supports the view that these changes are reporting artefacts rather than true changes in epidemiology.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The study did not propagate uncertainty in covariates used by cause-of-death models.
“Limits on computational resources mean we do not propagate uncertainty in the covariates used by cause of death models.”
Quote in the paperNot a substantial claim - Study design and conductnone given
The GBD study uses a highly standardised approach to address multiple measurement challenges in cause-of-death assessment, including variable vital registration completeness, garbage coding, verbal autopsy use, and missing data.
“The GBD study provides a highly standardised approach to dealing with the multiple measurement challenges in cause of death assessment, including variable completeness of vital registration (VR) data, levels and trends in the fraction of deaths assigned to garbage codes, the use of verbal autopsy (VA) studies in locations with incomplete VR, and overall data missingness.”
Quote in the paperSubstantial claim - Interpretationreasoning
The decline in HIV/AIDS death rates probably reflects successful expansion of ART and PMTCT programmes.
“HIV/AIDS mortality peaked in 2005 globally, with declining death rates probably reflecting the successful expansion of ART programmes and programmes focused on the prevention of mother-to-child transmission (PMTCT).”
Quote in the paperNot a substantial claim - Study design and conductreasoning
All included sources were adjusted to 100% completeness.
“Ultimately, all included sources were adjusted to 100% completeness by multiplying the cause fraction for a given location-age-sex-year by the estimated all-cause mortality for that location-age-sex-year.”
Quote in the paperSubstantial claim - Premisereasoning
The GBD study provides the only annual, comprehensive assessment of a detailed set of underlying causes disaggregated by age, sex, location, and year.
“The Global Burden of Disease (GBD) study, however, provides the only annual, comprehensive assessment of a detailed set of underlying causes disaggregated by age, sex, location, and year, enhancing opportunities to make comparisons across time and between locations.”
Quote in the paperSubstantial claim - Interpretationreasoning
The inclusion of the Sample Registration System offers a comprehensive picture of causes of death in India, particularly in rural areas.
“The inclusion of SRS for GBD 2016 offers a comprehensive picture of causes of death in India, particularly in rural areas.”
Quote in the paperNot a substantial claim - Study design and conductown data
CoDCorrect rescaled the sum of cause-specific estimates to equal draws from the all-cause mortality distribution.
“we used CoDCorrect to rescale the sum of cause-specific estimates to equal the draws from the all-cause distribution (appendix 1 p 280).”
Quote in the paperSubstantial claim - Study design and conductreasoning
CODEm uses multiple iterations of cross-validation to evaluate out-of-sample predictive validity of model variants.
“CODEm uses multiple iterations of cross-validation tests to evaluate the out-of-sample predictive validity of model variants that met predetermined requirements for direction and significance of regression coefficients.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
Data sources with more than 50% of deaths assigned to major garbage codes in a location-year were excluded from the GBD analysis.
“Because of the potential for bias, data sources with location-years with more than 50% of deaths assigned to major garbage codes were excluded from the GBD analysis.”
Quote in the paperSubstantial claim - Study design and conductreasoning
Vital registration sources less than 50% complete in any location were excluded.
“Due to the potential for selection bias in incomplete VR, we excluded VR sources that were less than 50% complete in any given location.”
Quote in the paperSubstantial claim - Interpretationown data
The global transition from premature mortality dominated by CMNN diseases to one dominated by NCDs and injuries is visible in the 37 years of GBD 2016 data.
“The global transition from a pattern of premature mortality dominated by CMNN diseases to one dominated by NCDs and injuries can be seen in the 37 years of data examined for GBD 2016.”
Quote in the paperSubstantial claim - Interpretationreasoning
The consistency of the finding of faster declines for larger initial YLL rates suggests it is unlikely to be due to chance alone.
“The consistency of this finding suggests that it is unlikely to be due to chance alone.”
Quote in the paperNot a substantial claim - Interpretationown data
The findings suggest that faster rates of decline were observed for causes with larger initial YLL rates.
“Generally, the findings suggest that we have observed faster rates of decline for causes with larger initial YLL rates.”
Quote in the paperNot a substantial claim - Interpretationnone given
Declining age-standardised rates but rising YLL numbers for NCDs such as breast cancer, oesophageal cancer, and ischaemic stroke are fundamentally driven by population growth and rising average population age.
“Declining age-standardised rates, but rising numbers of YLLs for non-communicable diseases, such as breast cancer, oesophageal cancer, and ischaemic stroke, are fundamentally driven by population growth and rising average population age.”
Quote in the paperSubstantial claim - Interpretationcitation
Differences in NCD progress are probably driven by factors including access to effective pre-hospital care, primary and secondary care services, diagnosis and management, availability and staffing of specialised units, and financing structures.
“These differences are probably driven by myriad factors, including access to effective pre-hospital care, differences in primary and secondary care services; improved diagnosis and management of many conditions; availability and staffing of specialised health units and related equipment required for more complex disease management or surgery; and financing structures.42,44”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [42] Tunstall-Pedoe, 1999, Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations, Lancet source
Not checked in the free run.
- cites [44] Haakenstad, 2016, Vaccine assistance to low- and middle-income countries increased to $3.6 billion in 2014, Health Aff (Millwood) source
Not checked in the free run.
- Interpretationcitation
The global shift toward NCDs for both sexes has been driven by population growth, ageing, and the epidemiological transition.
“The global shift toward NCDs for both sexes has been driven by the effects of population growth, ageing, and the epidemiological transition;3,25”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [3] Wang, 2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet source
Not checked in the free run.
- cites [25] Lozano, 2012, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
- Interpretationreasoning
Locations with lower star ratings have results that are more subject to change from data processing or model estimation.
“Because of the weaker empirical basis, results for locations with lower star ratings are more subject to change in how data are processed or models estimated;”
Quote in the paperNot a substantial claim - Study design and conductreasoning
Adjusting verbal autopsy studies relative to medical certification relies on a single available study, which is a limited basis for the adjustment.
“Fourth, in adjusting VA studies relative to medical certification, we rely on the single available study on this comparison;68 of necessity this is a limited basis for the adjustment.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Lozano, 2011, Performance of physician-certified verbal autopsies: multisite validation study using clinical diagnostic gold standards, Popul Health Metr source
Not checked in the free run.
- Study design and conductreasoning
For fatal discontinuities in countries with a 3-star data quality rating or lower, reliance on international organizations makes results subject to limitations in data coverage or representativeness.
“Third, in estimating fatal discontinuities for countries with a 3-star data quality rating or lower, we primarily relied on international organisations that collate these data, and thus our results are subject to the limitations in data coverage or representativeness of those sources;”
Quote in the paperNot a substantial claim - Interpretationreasoning
Changes in the earlier malaria time series mainly reflect refined covariates, including access to and efficacy of antimalarial drugs.
“Changes to estimates in the earlier part of the time series reflect mainly refined covariates, including access to and efficacy of antimalarial drugs.”
Quote in the paperNot a substantial claim - Premisecitation
Seven SDG indicators are based on cause-specific mortality measures beyond the Millennium Development Goal agenda.
“Seven SDG indicators are based on measures of cause-specific mortality beyond the Millennium Development Goal agenda, specifically death rates due to natural disasters (SDG 1.5.1, 11.5.1, and 13.1.2); cardiovascular disease, cancer, diabetes, and chronic respiratory disease among 30–70-year-olds (SDG 3.4.1); self-harm (SDG 3.5.1); road injuries (SDG 3.6.1); unintentional poisonings (SDG 3.9.3);”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] 2016
Not checked in the free run.
- Interpretationown data
High-quality death certification is achievable at the national level.
“Countries such as Finland, Moldova, New Zealand, Singapore, and that have less than 5% of deaths on average since 2010 assigned to major garbage codes strongly imply that high-quality certification is possible at the national level.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
Uncertainty from statistical models used for many garbage code redistribution algorithms has not been systematically carried through to final estimates.
“Ninth, we have not been able to systematically carry uncertainty from the statistical models used for many of the garbage code redistribution algorithms through to our final estimates due to limitations in computational requirements and storage needed;”
Quote in the paperNot a substantial claim - Study design and conductnone given
The newly developed location data quality ratings do not incorporate the extent of redistribution for miscoded causes or other error sources that may affect estimation accuracy.
“First, the newly developed data quality ratings by location do not incorporate the extent of redistribution for miscoded causes of death or other sources of error that might affect the accuracy of estimation based on those data.”
Quote in the paperNot a substantial claim - Interpretationcitation
IARC mortality-to-incidence ratio estimates in the lower three SDI quintiles are low for several important cancers, especially where access and quality of care have clear effects.
“We believe that the IARC estimates of MIR in the lower three SDI quintiles are low for a number of important cancers, particularly where there is clear evidence of the impact of access and quality of care, and empirical evidence of this gradient from recent analyses employing the Healthcare Access and Quality Index.43”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Dieleman, 2016, Development assistance for health: past trends, associations, and the future of international financial flows for health, Lancet source
Not checked in the free run.
- Interpretationreasoning
For locations with five-star ratings, future GBD results are unlikely to change even if model life tables improve or garbage code redistribution changes.
“In settings with five stars, the results in future iterations of GBD are unlikely to change even if the model life tables improve or there are changes in how garbage codes are redistributed.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The global decline in major garbage coding was caused by ongoing improvements in data collection and recording.
“At the global level, the fraction of all registered deaths assigned to major garbage codes decreased over the past 37 years, owing to ongoing improvements in data collection and recording.”
Quote in the paperNot a substantial claim
- May combine two claims. 91
- Classified as probably not a substantial claim. 22
May combine two claims.
Findingown dataMost countries with a 5-star time-series rating were high-SDI, but some high-SDI countries such as France, Poland, and Puerto Rico were rated 4 stars.
“While most countries with a 5-star time series rating were high-SDI countries, some high-SDI countries were rated at 4 stars, such as France, Poland, and Puerto Rico.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataYears of life lost were notably lower than expected for neonatal preterm birth complications in many locations in south Asia and southeast Asia, and for cerebrovascular disease in western Europe.
“Other leading causes of YLLs for which YLLs were notably lower than expected included neonatal preterm birth complications in many locations in both south Asia and southeast Asia, and cerebrovascular disease in western Europe.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
May combine two claims.
Findingown dataCommunicable diseases declined as a leading source of death, and reductions in HIV/AIDS, malaria, tuberculosis, and diarrhoeal diseases drove much of that decline.
“Generally, communicable diseases decreased as a leading source of death, and much of this decrease was driven by reductions in large contributors to global mortality, including HIV/AIDS, malaria, tuberculosis, and diarrhoeal diseases (table 2).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThe GBD 2016 version of the Socio-demographic Index correlates with the GBD 2015 version at 0.977 (p<0.0001).
“the correlation of the GBD 2015 and GBD 2016 versions of SDI is 0·977 (p<0·0001)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] 2017, Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet source
Not checked in the free run.
May combine two claims.
Findingown dataBetween 1990 and 2016, total deaths declined in age groups 0-6 days, 7-27 days, 28-364 days, 1-4 years, 5-9 years, 10-14 years, 15-19 years, and 20-24 years, and increased by more than 60% in age groups 80-84, 85-89, 90-94, and 95 years and older.
“Total deaths declined in the age group intervals of 0–6 days, 7–27 days, 28–364 days, 1–4 years, 5–9 years, 10–14 years, 15–19 years, and 20–24 years, and increased by more than 60% in age groups 80–84 years, 85–89 years, 90–94 years, and 95 years and older.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
May combine two claims.
Findingown dataTuberculosis caused an estimated 1.21 million deaths in 2016, a 20.9% decrease since 2006.
“An estimated 1·21 million deaths (95% UI 1·16 million to 1·27 million) were caused by tuberculosis in 2016, a decrease of 20·9% (17·9–24·5) since 2006.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFrom 2006 to 2016, the ten leading causes by age-standardised years of life lost rate fell with a median annualised change of −2.89%, while all other causes had a median annualised change of −1.59%.
“The ten leading causes by rates of age-standardised YLL significantly decreased from 2006 to 2016 (median annualised rate of change was a decrease of 2·89%); the median annualised rate of change for all other causes was lower (a decrease of 1·59%) during the same interval.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
May combine two claims.
Findingown dataIn 2016, 25 countries had 5-star data quality, 48 had 4 stars, 30 had 3 stars, 21 had 2 stars, and 44 had 1 star.
“Using this rating system, 25 countries were assigned 5 stars, 48 countries had 4 stars, 30 countries had 3 stars, 21 countries had 2 stars, and 44 countries were assigned 1 star (figure 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataYears of life lost increased globally for causes such as diabetes mellitus and some neoplasms, and in some locations for causes such as drug use disorders and conflict and terrorism.
“YLLs have increased globally for causes such as diabetes mellitus or some neoplasms, and in some locations for causes such as drug use disorders, and conflict and terrorism.”
Quote in the paperSubstantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSome high-middle-SDI countries such as Argentina, Brazil, and Israel received 4-star data quality ratings.
“Some high-middle-SDI countries such as Argentina, Brazil, and Israel also received data quality ratings of 4 stars.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFrom 2006 to 2016, total deaths from communicable, maternal, neonatal, and nutritional diseases fell by 23.9% (95% UI 21.6-26.1), and their age-standardised death rate fell by 32.3% (30.3-34.2).
“total CMNN deaths decreased by 23·9% (95% UI 21·6–26·1), while age-standardised death rates decreased by 32·3% (30·3–34·2).”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
May combine two claims.
Findingown dataFor people older than 70, causes of death that increased by more than 90% between 1990 and 2016 included neurological disorders; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; other non-communicable diseases; musculoskeletal disorders; and mental and substance use disorders.
“Causes of deaths for those aged older than age 70 years that increased by more than 90% were neurological disorders; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; other non-communicable diseases; musculoskeletal disorders; and mental and substance use disorders.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
May combine two claims.
Findingown dataBetween 1990 and 2016, deaths at ages 90-94 increased by 178% (95% UI 176-181) and deaths at ages 95 years and older increased by 210% (208-212).
“Between 1990 and 2016, a profound shift toward deaths at older ages occurred with a 178% (95% UI 176–181) increase in deaths in ages 90–94 years and a 210% (208–212) increase in deaths older than age 95 years.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
May combine two claims.
Findingown dataFrom 2006 to 2016, the global age-standardised death rate from non-communicable diseases fell by 12.1% (95% UI 10.6-13.4), reaching 614.1 deaths per 100,000 in 2016.
“the global age-standardised NCD death rate decreased 12·1% (10·6–13·4), to 614·1 deaths (603·0–625·3) per 100 000 in 2016.”
Quote in the paperNot a substantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
May combine two claims.
Findingown dataIncreases greater than 30% occurred for prostate cancer, pancreatic cancer, and other neoplasms from 2006 to 2016.
“From 2006 to 2016, increases of greater than 30% occurred for several neoplasms that were large causes of deaths (greater than 200 000 in 2016): prostate cancer (30·8% [95% UI 24·5–36·6], to 381 000 deaths [321 000–413 000]); pancreatic cancer (30·2% [26·2–33·7], to 405 000 deaths [394 000–416 000]); and other neoplasms (30·0% [24·5–33·0], to 431 000 deaths [393 000–444 000]).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe largest decreases in injury deaths from 2006 to 2016 were for exposure to forces of nature and drowning, while the largest increase was for conflict and terrorism.
“The largest decreases in injury deaths from 2006 to 2016 occurred for exposure to forces of nature (49·2% [95% UI 35·2–63·2], to 7060 deaths [4220–10 100]) and drowning (19·0% [13·3–22·2], to 303 000 deaths [273 000–322 000]), while the largest increase was for conflict and terrorism at 143·3% (42·6–370·6), from 61,900 deaths (33 100 to 91 000) deaths to 150 000 deaths [101 400–202 700]).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDengue was the only neglected tropical disease with a significant increase in cause-specific mortality, with total deaths rising 81.8% from 20 800 in 2006 to 37 800 in 2016.
“Dengue was the only NTD with a significant increase in cause-specific mortality, with an 81·8% (95% UI 42·3–132·6) increase in total deaths, from 20 800 deaths (6000–26 500) in 2006 to 37 800 (10 900–52 700) deaths in 2016”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNutritional deficiencies accounted for 3.49% of total CMNN deaths, or 368 100 deaths in 2016.
“Deaths from nutritional deficiencies constituted 3·49% (95% UI 3·31–3·79) of total deaths due to CMNN causes, resulting in 368 100 (334 000–422 700) in 2016.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPost-neonatal deaths decreased 34.5% to 1.49 million, and deaths among children aged 1-4 years decreased 37.2% to 1.35 million between 2006 and 2016.
“Total deaths among post-neonates (aged 28–364 days) and children aged 1–4 years decreased between 2006 and 2016 by 34·5% (95% UI 31·3–37·4) to 1·49 million deaths (1·42 million to 1·55 million) and 37·2% (33·3–40·5) to 1·35 million deaths (1·28 million to 1·43 million), respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataUnintentional injuries accounted for the most injury deaths in 2016, with 1.80 million deaths, mainly from falls, drowning, and exposure to mechanical forces.
“Unintentional injuries accounted for the most injury deaths in 2016, with 1·80 million deaths (95% UI 1·59 million to 1·89 million) composed mainly of deaths from falls (678 000 deaths [559 000–719 000]), drowning (302 000 deaths [273 000–322 000]), and exposure to mechanical forces (155 000 deaths [124 000–165 000]).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataChronic respiratory diseases contributed 8.96% of NCD deaths in 2016, with COPD causing the most deaths from these conditions (2.93 million).
“Chronic respiratory diseases contributed 8·96% of NCD deaths in 2016, with chronic obstructive pulmonary disease (COPD) leading to the most deaths from these conditions (2·93 million deaths [95% UI 2·82 million to 3·12 million]).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn 2016 there were 5.00 million under-5 deaths, a 33.0% decrease from 7.46 million in 2006.
“In 2016 there were 5·00 million deaths (95% UI 4·78 million to 5·23 million) in children under 5, a decrease of 33·0% (29·7–36·2) from 2006, when 7·46 million (7·27 million to 7·66 million) children died.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDiabetes absolute deaths increased 31.1% and total YLLs increased 25.3% between 2006 and 2016, while age-standardised YLL rates decreased 2.12%.
“The absolute number of deaths and the total YLLs from diabetes both increased between 2006 and 2016 by 31·1% (95% UI 28·9–33·4) and 25·3% (23·2–27·7), respectively, while age-standardised YLL rates decreased 2·12% (0·29–3·81) over the same time period.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAge-standardised rates did not change significantly globally for amphetamine use disorders, opioid use disorders, or other drug use disorders from 2006 to 2016.
“while rates did not change significantly on a global scale for amphetamine use disorders, opioid use disorders, or other drug use disorders over that time period.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAge-standardised death rates fell across most neoplasms, most notably for stomach cancer (22.5% decrease to 12.6 per 100 000) and Hodgkin's lymphoma (22.4% decrease to 0.4 per 100 000).
“Age-standardised death rates fell across most neoplasms, most notably for stomach cancer (decrease of 22·5% [95% UI 20·7–24·5], to 12·6 deaths [12·3–12·9] per 100 000 in 2016) and Hodgkin’s lymphoma (decrease of 22·4% [19·9–25·3], to 0·4 deaths [0·4–0·5] per 100 000 in 2016).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn 2016, the largest numbers of NCD deaths at Level 2 were from cardiovascular diseases (17.6 million), neoplasms (8.93 million), and chronic respiratory diseases (3.54 million).
“For NCDs in 2016, the largest number of deaths at Level 2 were caused by cardiovascular diseases (17·6 million deaths [95% UI 17·3 million to 18·1 million]) followed by neoplasms (8·93 million deaths [8·75 million to 9·09 million]), and chronic respiratory diseases (3·54 million deaths [3·40 million to 3·74 million]; table 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataProtein-energy malnutrition resulted in 1.22 million deaths globally from 1980 to 2016, largely in eastern sub-Saharan Africa and North Africa and the Middle East during the 1980s and in East Asia from 1995 through 2002.
“Protein-energy malnutrition resulted in 1·22 million (95% UI 670 000 to 1·81 million) deaths globally from 1980 to 2016 (figure 4C), a total that is largely composed of mortality in eastern sub-Saharan Africa and North Africa and the Middle East during the 1980s, and in countries in ast Asia from 1995 through 2002.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn 2016, transport injuries caused 1.44 million deaths and self-harm and interpersonal violence caused 1.21 million deaths.
“In terms of number of deaths in 2016, unintentional injuries were followed by transport injuries (1·44 million deaths [95% UI 1·40 million to 1·49 million]), and self-harm and interpersonal violence (1·21 million deaths [1·11 million to 1·29 million]).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNeonatal deaths decreased 28.9% from 3.04 million in 2006 to 2.16 million in 2016, with decreases across all mortality sources but non-significant differences for neonatal sepsis and other neonatal infections.
“Deaths in this group decreased by 28·9% (95% UI 25·5–32·1) from 2006 to 2016, from 3·04 million (2·97 million to 3·12 million) to 2·16 million (2·06 million to 2·27 million); these decreases occurred across all mortality sources, although differences were not significant for neonatal sepsis and other neonatal infections.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong the leading ten causes of YLLs, the median rate of change was a decrease of 2.89%, higher than the median decrease of 1.59% for causes below the leading ten.
“Among the leading ten causes of YLLs, the median rate of change was a decrease of 2·89%, higher than the median rate of change (decrease of 1·59%) for causes below the leading ten for YLLs.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPhysical violence by firearm was the largest portion (41.2%) of overall interpersonal violence in 2016, and its age-standardised death and YLL rates decreased from 2006 to 2016.
“Deaths from physical violence by firearm were the largest portion (41·2%) of overall interpersonal violence in 2016; globally, age-standardised rates for deaths and for YLLs of physical violence by firearm decreased from 2006 to 2016 by 5·34% (95% UI 0·80–9·52) and 5·19% (0·51–9·71), respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGlobal Zika virus disease deaths were two in 2015 and 19 in 2016.
“The global number of deaths from Zika virus disease—newly estimated for GBD 2016— was two deaths (95% UI 1–5) in 2015 and 19 deaths (4–57) in 2016.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNatural disasters were large contributors to fatal discontinuities between 1980 and 2016, with high mortality years in South Asia, Southeast Asia, East Asia, and the Caribbean.
“Generally reflecting single large events within regions, high mortality levels from exposure to forces of nature were estimated for the years 1991 (143 000 [95% UI 65 000–222 000] deaths in South Asia), 2004 (214 000 [127 000–297 000] deaths in Southeast Asia), 2008 (141 000 [73 400–209 000] deaths in Southeast Asia, and 96 300 [15 300–185 000] deaths in East Asia), and 2010 (231 000 [36 700–443 0”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll maternal and neonatal causes of death decreased globally in both total deaths and age-standardised death rates between 2006 and 2016.
“All maternal and neonatal causes of death decreased globally in terms of both total deaths and age-standardised death rates between 2006 and 2016.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEpidemic-prone infectious diseases caused fatal discontinuities from 1980 to 2016, with peak years in 1991, 1996, and 2014 dominated by outbreaks in western sub-Saharan Africa.
“Epidemic-prone infectious diseases also resulted in fatal discontinuities from 1980 to 2016 (figure 4B) with peak years in 1991, 1996, and 2014 dominated by mortality from infectious disease outbreaks in western sub-Saharan Africa.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe median annualised rate of change for the leading causes of YLLs was a decrease of 2.89%, compared with 1.59% for the remainder of causes.
“The median annualised rate of change for this set of leading causes of YLLs was a decrease of 2·89%, compared with 1·59% for the remainder of causes in the hierarchy.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn low-SDI locations, shifts in cause rankings by YLLs from 2006 to 2016 occurred beyond the top ten causes, with many CMNN causes decreasing in rank and being surpassed by NCD causes and injuries.
“In low-SDI locations, shifts in cause rankings by YLLs from 2006 to 2016 occurred beyond the top ten causes, with many CMNN causes decreasing in rank, surpassed by NCD causes and injuries.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationAbsolute numbers of YLLs increased for NCDs in all but the high-SDI quintile, alongside steadily increasing life expectancy in most locations.
“While declines in age-standardised YLL rates are an indicator of progress, the absolute numbers of YLLs increased for NCDs in all but the high-SDI quintile; these increases in absolute YLLs from NCDs occurred in tandem with steadily increasing life expectancy in most locations worldwide.21”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] 2017, Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet source
Not checked in the free run.
May combine two claims.
Findingown dataIschaemic heart disease was common among Latin American and Caribbean countries, ranking in the leading three causes in all countries in the region, and lower respiratory infections were commonly within the leading five causes in South Asia and sub-Saharan Africa.
“Nonetheless, ischaemic heart disease was common among countries of Latin America and the Caribbean, ranking in the leading three causes in all countries in the region, and lower respiratory infections were also commonly within the leading five causes of YLLs in South Asia and sub-Saharan Africa.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNCDs surpassed CMNN diseases in global all-ages YLL rate in 2009 and in age-standardised rates in 1992.
“NCDs surpassed CMNN diseases in terms of global all-ages YLL rate in 2009 and earlier—in 1992—for age-standardised rates.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataObserved YLL levels much higher than expected on the basis of SDI were most commonly noted for HIV/AIDS and malaria in sub-Saharan Africa, diabetes in Oceania, and cardiomyopathy and myocarditis in eastern and central Europe.
“The opposite, where observed levels were much higher than expected on the basis of SDI, was most commonly noted in the case of HIV/AIDS and malaria in sub-Saharan Africa; diabetes mellitus, especially in Oceania; and cardiomyopathy and myocarditis, particularly in eastern and central Europe.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong the three broad Level 1 cause groups, rates of change for age-standardised YLLs were more heterogeneous for CMNN causes than for non-communicable causes, with the least variation for injuries.
“Between the three broad Level 1 cause groups, there was greater heterogeneity in rates of change for age-standardised YLLs for CMNN causes compared with non-communicable causes, while the least variation occurred for injuries.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor men, conflict was a leading cause of YLLs in Syria, Yemen, and Afghanistan, and self-harm was a leading cause in Greenland and South Korea.
“A few leading causes stand out for their departure from global or regional patterns; for men these included conflict in Syria, Yemen, and Afghanistan, and self-harm in Greenland and South Korea.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIschaemic heart disease was the leading cause of YLLs for men in 113 countries and for women in 97 countries.
“Ischaemic heart disease was the leading cause of YLLs for men in 113 countries and for 97 countries for women, spanning both high-SDI and high-middle SDI locations as well as many lower SDI locations, such as Kyrgyzstan.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn China, lung, liver, stomach, and oesophageal cancers were within the leading ten causes of YLLs and each caused higher than expected YLLs on the basis of SDI.
“In China, a number of cancers—lung cancer, liver cancer, stomach cancer, and oesophageal cancer—were within the leading ten causes of YLLs, and each of these caused higher than expected levels of YLLs on the basis of SDI; from 1·70 times higher for lung cancer to 5·43 times higher for liver cancer.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOther leading causes with observed YLLs notably lower than expected included neonatal preterm birth complications in south and southeast Asia and cerebrovascular disease in western Europe.
“Other leading causes for which observed YLLs were notably lower than expected included neonatal preterm birth complications in many countries of both south Asia and southeast Asia, and cerebrovascular disease in western Europe.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere was no change from 2006 to 2016 in the leading three causes of YLLs for high-SDI, high-middle-SDI, and middle-SDI locations, although age-standardised YLL rates decreased for each of these causes.
“There was no change from 2006 to 2016 in the leading three causes of YLLs for high-SDI, high-middle-SDI, and middle-SDI locations, although age-standardised YLL rates decreased for each of these causes (figure 7A–C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNCD age-standardised YLL rates declined for each SDI quintile from 1980 to 2016, with the slowest decline at low SDI and the fastest at high SDI.
“NCD age-standardised YLL rates also declined for each SDI quintile from 1980 to 2016, but rates of decline were slowest at low SDI and fastest for high SDI.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOver the 37-year period, global HIV/AIDS deaths rose from 4224 in 1980, peaked in 2005 at 1.91 million, and declined to 1.03 million in 2016.
“Over the 37-year period analysed here, global deaths due to the HIV/AIDS epidemic rose from 4224 deaths (95% UI 2842–6274) in 1980, peaked in 2005 at 1·91 million (1·81 million to 2·01 million), and declined to 1·03 million (0·99 million to 1·08 million) in 2016.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAcross much of sub-Saharan Africa, the leading cause of YLLs for both sexes varied between HIV/AIDS, malaria, diarrhoeal diseases, and lower respiratory infections; for men in the Central African Republic, tuberculosis was the leading cause.
“Across much of sub-Saharan Africa, the leading cause for both men and women varied between HIV/AIDS, malaria, diarrhoeal diseases, and lower respiratory infections; however, for men in the Central African Republic, tuberculosis was the leading cause.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe causes contributing the most YLLs varied with location, although regional and SDI-associated patterns were evident.
“however, the causes that contributed the most YLLs varied with location—although regional patterns and patterns associated with SDI were also evident.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe largest reduction in age-standardised YLL rates for high-SDI locations came from road injuries, which fell 25.2%, while the largest increase was for drug use disorders, which rose 18.9%.
“The largest reduction in age-standardised YLL rates for high-SDI locations came from road injuries, which fell by 25·2% (95% UI 22·5–27·6), while the largest increase was for drug use disorders (rising by 18·9% [13·8–23·3]).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere was considerably more heterogeneity in trends by SDI quintile and GBD region or location, with 36 countries having significant increases in age-standardised YLLs across 3 or more Level 3 causes.
“For SDI quintiles, and by GBD regions or locations, there was considerably more heterogeneity in trends—eg, 36 countries had significant increases in age-standardised YLLs across 3 or more of Level 3 causes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn 2016, the leading 30 causes of all-age YLLs for high-SDI locations were predominantly NCDs and injuries, with one CMNN cause, lower respiratory infections, within the leading 30.
“In 2016, the leading 30 causes of all-age YLLs for high-SDI locations were predominantly from NCDs and injuries, with one CMNN cause—lower respiratory infections—within the leading 30 causes (figure 7A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAge-standardised YLL rates due to injuries varied least across quintiles and over time but were highest in the low-SDI quintile.
“Age-standardised YLL rates due to injuries varied the least across quintiles and over time but were highest in the low-SDI quintile.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe transition was characterised by declining CMNN disease rates in all SDI quintiles, with faster declines in lower-SDI quintiles.
“This transition was characterised by declining rates of CMNN diseases in all SDI quintiles, with faster rates of decline in lower-SDI quintiles.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataInjury age-standardised YLL rates declined in each SDI quintile, although this was punctuated by large increases in some years due to fatal discontinuities.
“Injury age-standardised YLL rates declined in each SDI quintile, although this was punctuated by large increases in some years due to fatal discontinuities from conflict and terrorism, disasters, and epidemics.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn all SDI quintiles, age-standardised NCD rates decreased, with the slowest decline in low SDI and the fastest in high SDI.
“In all quintiles, age-standardised rates for NCDs have decreased; by contrast with trends for CMNN causes, the pace of decline for NCD rates was slowest in low SDI and fastest in high SDI.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationGlobal reductions in age-standardised death rates due to hepatitis C have largely stagnated since 2010 despite the availability of a highly effective cure, and in the USA total hepatitis C deaths have surpassed deaths from all other notifiable infectious diseases.
“Globally, reductions in age-standardised death rates due to hepatitis C have largely stagnated since 2010 even though a highly effective cure is available—and in the USA, total deaths from hepatitis C have now surpassed deaths from all other notifiable infectious diseases,49”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] McMichael, 2006, Climate change and human health: present and future risks, Lancet source
Not checked in the free run.
May combine two claims.
FindingreasoningThe new SRS data changed India results and, by changing regression coefficients, also modified estimates for other locations with lower data-quality star ratings.
“In some cases, the new SRS data over a 10-year period not only changed results for India but, through changing coefficients in regression models, also modified estimates for other locations that were lower in the stars system of data quality rankings developed for GBD 2016.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGlobal Zika virus deaths were estimated at 2 (95% UI 1-5) in 2015 and 19 (4-57) in 2016.
“The global number of Zika virus deaths was comparatively small—estimated at two (95% UI 1–5) in 2015 and 19 (4–57) in 2016.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningThe GBD drug-resistant tuberculosis share is lower than WHO's 13.9% for the same year because of different composition of drug-resistant types.
“Due to the different composition of drug-resistant types, these numbers are lower than the 13·9% of drug-resistant tuberculosis deaths (multidrug-resistant and rifampicin-resistant tuberculosis combined) among all tuberculosis deaths reported by WHO for the same year.6”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] 2016
Not checked in the free run.
May combine two claims.
Findingown dataMalaria changes in India were most pronounced and were driven by inclusion of improved SRS mortality data, which lowered estimates in all years, especially earlier years.
“Changes in India were most pronounced and driven by inclusion of the much-improved SRS mortality data, which lowered estimates in all years, but particularly earlier years.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataUpdates to malaria data and methods in GBD 2016 changed estimates of both recent malaria mortality and trends over time.
“Updates in the data collated and improvements to the methodological approach for malaria mortality estimation in the GBD 2016 iteration have resulted in changes in estimates of both contemporary mortality and trends through time.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAlzheimer's disease and other dementias and chronic kidney disease ranked fourth and 11th among leading causes of death globally and are increasing sources of health burden, particularly in low-SDI to middle-SDI locations.
“Two causes—Alzheimer’s disease and other dementias, and chronic kidney disease, ranked fourth and 11th, respectively, among the leading causes of death globally—are increasing sources of health burden, particularly for low-SDI to middle-SDI locations; however, the SDG agenda offers at best a minimal platform for drawing attention to the health care and monitoring needs of these conditions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenData quality improved in some large countries, including Brazil, China, and India.
“The improvements in data quality in some large countries, such as Brazil, China, and India, is particularly encouraging.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningGlobal deaths from other pharynx cancers in 2010 increased by 72.3% for men and 73.8% for women compared with GBD 2015, mostly from India.
“For example, estimates of deaths from other pharynx cancers in 2010 at the global level increased by 72·3% for men and by 73·8% for women; most of this increase comes from India.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe proportional decline in malaria deaths between 2006 and 2015 is estimated at 27.9% (95% UI 8.71-42.8), smaller than WHO's estimated 42% (33-55).
“As such, the proportional decline in malaria deaths between 2006 and 2015 is now estimated to be 27·9% (95% UI 8·71–42·8), which is smaller than the WHO estimated decline of 42% (33–55).7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] 2016
Not checked in the free run.
May combine two claims.
Findingown dataGlobal deaths from Hodgkin's lymphoma in 2010 increased by 28.1% for men and 16.8% for women compared with GBD 2015, mainly from sub-Saharan Africa due to more registry data.
“Estimates for deaths from Hodgkin’s lymphoma in 2010 increased by 28·1% for men and by 16·8% for women compared with GBD 2015 at the global level. This difference comes mainly from an increase in the mortality estimates for sub-Saharan Africa, where the inclusion of more registry data for Nigeria, Uganda, and other locations changed the estimates.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningGlobal malaria estimates for the most recent years are slightly higher than in GBD 2015, while earlier years, including the early-2000s peak, are lower.
“At the global level, estimates for malaria in the most recent years are slightly higher compared with those in GBD 2015, but earlier years were estimated to be lower, including the years of peak global malaria mortality in the early 2000s.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningThe revised tuberculosis modelling strategy did not majorly change general conclusions on global tuberculosis epidemiology, although global deaths were slightly higher than in GBD 2015 for all years.
“This, together with the addition of SRS data for India and changes to the mortality envelope, has not resulted in major changes to our general conclusions on the global epidemiology of tuberculosis, although the number of deaths at the global level was slightly higher than that of GBD 2015 for all years.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGlobal health patterns are changing, with more rapid declines in communicable, maternal, neonatal, and nutritional conditions than in other diseases and injuries.
“Patterns of global health are clearly changing, with more rapid declines in CMNN conditions than for other diseases and injuries.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEgypt, Thailand, and Turkey each had more than 50% of deaths assigned to major garbage categories.
“By contrast, some systems, such as those in Egypt, Thailand, and Turkey, have more than 50% of deaths assigned to major garbage categories.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEstimated tuberculosis deaths increased significantly in several African countries; Nigeria and Zambia had more than twice the estimated deaths in 2015.
“The estimated number of deaths in several African countries have significantly increased; Nigeria and Zambia were notable with more than twice the number of estimated deaths in 2015.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGlobal deaths from other neoplasms in 2010 increased by 20.3% for men and 5.1% for women compared with GBD 2015, mainly due to redistribution of myelodysplastic syndrome.
“Compared with in GBD 2015, estimated deaths in 2010 due to other neoplasms increased by 20·3% for men and by 5·1% for women. This increase was mainly due to a change in redistribution of myelodysplastic syndrome, which was redistributed to the leukaemia subcauses for GBD 2015, and to other neoplasms for GBD 2016.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn Western Europe, overall early neonatal death rates from neonatal disorders are similar across the region, but death rates within Level 3 causes differ by as much as three-fold.
“Western Europe is an example where the overall death rate due to neonatal disorders in the early neonatal period is quite similar across the region, but there is as much as a three-fold difference in death rates within Level 3 causes (eg, neonatal preterm birth complications, cardiovascular diseases).65,66”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [65] Delnord, 2017, Variations in very preterm birth rates in 30 high-income countries: are valid international comparisons possible using routine data?, BJOG source
Not checked in the free run.
- cites [66] Roth, 2017, Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015, J Am Coll Cardiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe MCEE group reports estimates for 15 cause groups of child death for 194 countries for 2000-15.
“The latest assessment from the Maternal and Child Epidemiology Estimation (MCEE) group reports estimates for 15 cause groups of child death for 194 countries for the period 2000–15,18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll authors had full access to the data and final responsibility for the decision to submit for publication.
“All authors had full access to the data in the study and had final responsibility for the decision to submit for publication.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationWHO's Global Health Estimates programme published estimates for 176 causes of death for 183 countries from 2000 to 2015.
“while the Global Health Estimates (GHE) programme through WHO recently published estimates for 176 causes of death for 183 countries from 2000 to 2015.19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] 2016
Not checked in the free run.
May combine two claims.
Study design and conductnone givenIndependent CODEm models were run for each cause by sex and separately for countries with and without extensive complete vital registration data.
“Independent CODEm models were run for each cause of death by sex, and separately for countries with and without extensive complete VR data.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataCODEm models were combined into a weighted ensemble, with models performing best on out-of-sample prediction error for levels and trends weighted highest.
“These models were then combined into a weighted ensemble model, with models performing best on out-of-sample prediction error of both levels and trends weighted highest.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningThe entire GBD time series was re-estimated to ensure comparisons used a consistent dataset and methods.
“As with each annual cycle of GBD, the entire time series was re-estimated to ensure that all comparisons are made using a consistent dataset and methods; these results, therefore, supersede all previously published GBD cause of death estimates.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataOver the past 37 years, rates of communicable, maternal, neonatal, and nutritional diseases declined across all SDI quintiles, with faster than expected gains for many locations relative to their SDI.
“The past 37 years have featured declining rates of communicable, maternal, neonatal, and nutritional diseases across all quintiles of SDI, with faster than expected gains for many locations relative to their SDI.”
Quote in the paperSubstantial claim- Rests on an assumption: The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
- Rests on an assumption: Each death can be assigned to a single underlying cause according to ICD principles.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe funder had no role in study design, data collection, data analysis, data interpretation, or writing the report.
“The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenGBD 2016 followed the GATHER guidelines for development and documentation.
“As in GBD 2015, we follow the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) for the development and documentation of GBD 2016 (appendix 1 p 292).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRapid progress to reduce mortality is possible for some causes, as shown by documented declines in cardiovascular disease death rates in central Europe and decreasing malaria mortality in eastern sub-Saharan Africa.
“Rapid progress to reduce mortality is possible for some causes, as evidenced by previously documented declines in central Europe for cardiovascular disease death rates or decreasing mortality from malaria in eastern sub-Saharan Africa.3”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Wang, 2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet source
Not checked in the free run.
May combine two claims.
InterpretationreasoningInternational declarations and agreements for development and health have generally focused on CMNN-related indicators, and this focus is reflected in the rapid reductions in CMNN diseases achieved by lower-SDI locations.
“International declarations and agreements for development and health have attracted political actions at the highest level but have also generally focused on indicators related to CMNN causes. This focus is reflected in the rapid reductions in CMNN diseases achieved by lower-SDI locations over the past four decades.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningGlobal progress in mortality has been neither universal nor uniform.
“Globally, progress has been neither universal nor uniform.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe quality of data available for estimating global causes of death improved, and with the new rating system 50 countries had a higher star rating in 2010-16 than their overall rating since 1980.
“The quality of data available for estimating the global causes of death has improved; with the new rating system reported here, 50 countries had a higher star rating in the most recent period (2010–16) compared with their overall rating since 1980.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIncreasing YLLs and higher chronic disease prevalence will drive rising health service needs and pose financial, workforce, and managerial challenges for health systems.
“Increasing numbers of YLLs and the associated higher prevalence of chronic diseases will drive rising needs for health service provision and pose substantial financial, workforce capacity, and managerial challenges for health systems.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationUntil the 2015 adoption of the SDGs, NCDs were not strong priorities in international declarations and did not receive equivalent political commitment in many locations.
“However, until the 2015 adoption of the SDGs, NCDs were not strong priorities in these declarations and did not receive equivalent levels of political commitment in many locations.45–47”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [45] Bollyky, 2015, Understanding the relationships between noncommunicable diseases, unhealthy lifestyles, and country wealth, Health Aff (Millwood) source
Not checked in the free run.
- cites [46] Anderson, 2016, Tobacco control progress in low and middle income countries in comparison to high income countries, Int J Environ Res Public Health source
Not checked in the free run.
- cites [47] Ly, 2016, Rising mortality associated with hepatitis C virus in the United States, 2003–2013, Clin Infect Dis source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPast studies show that access to high-quality personal health care affects both communicable and non-communicable diseases.
“Past studies show the effect of access to high-quality personal health care on both communicable and non-communicable diseases, highlighting the importance of prioritising personal health-care access and quality for all populations across the development spectrum.39–42”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [39] Nolte
Not checked in the free run.
- cites [40] Barber, 2017, Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015, Lancet source
Not checked in the free run.
- cites [41] Ford, 2007, Explaining the decrease in U.S. deaths from coronary disease, 1980–2000, N Engl J Med source
Not checked in the free run.
- cites [42] Tunstall-Pedoe, 1999, Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations, Lancet source
Not checked in the free run.
May combine two claims.
Interpretationown dataLarge differences in neonatal cause-of-death patterns between countries with nearly the same SDI in the same GBD region are likely not real and are suspected to reflect variation in medical culture in assigning neonatal deaths.
“There is no reason to believe that these large differences in the causes of deaths in the first month of life between countries with nearly the same SDI in the same GBD region are real; rather, we strongly suspect there is variation in medical culture in how neonatal deaths are assigned.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDengue and its four serotypes have continued to increase and expand globally.
“The continued global increase and expansion of dengue and its four serotypes is a potential indicator of the complex changes that are underway and might be partly related to changes in climate in addition to other factors.61”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Messina, 2014, Global spread of dengue virus types: mapping the 70 year history, Trends Microbiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIt is unclear whether bias from underestimated IARC MIRs primarily affects IARC incidence estimates or site-specific mortality estimates.
“Due to the complexities of the IARC estimates, if the bias in their estimates from underestimated MIRs primarily affects their estimates of incidence or the site-specific mortality estimates is unclear.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIARC Globocan estimates do not currently meet GATHER guidelines.
“The Globocan project at IARC produces estimates of major cancer types on a periodic basis for 184 countries; IARC estimates do not currently meet GATHER guidelines.15”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] 2017
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAs recognized in the GHE 2015 technical paper, GBD remains the only source of comprehensive uncertainty estimates for mortality by cause.
“The GBD study, as recognised in the GHE 2015 technical paper, remains the “only source of comprehensive uncertainty estimates for mortality by cause.”19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationImprovements to broader social determinants of health might be less developed in low-SDI locations; for example, low-income and middle-income countries lag in implementing evidence-based tobacco control regulation.
“In addition to the role of health care, improvements to the broader social determinants of health might be less developed in low-SDI locations—eg, low-income and middle-income countries lag behind in implementing evidence-based tobacco control regulation.48”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Patz, 2005, Impact of regional climate change on human health, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenA low level of identified garbage coding for a location does not necessarily indicate quality or accuracy in cause-of-death certification.
“Seventh, a low level of identified garbage coding for a given location does not necessarily indicate quality or accuracy in cause of death certification.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningGBD 2015 mortality-to-incidence ratios did not capture likely effects of worse treatment access in lower-SDI settings, and the revised MIR approach better captures the relationship between MIR and health-system access and quality of care.
“GBD 2015 estimated MIRs did not capture the likely effects of worse access to treatment in lower-SDI settings; we have revised the MIR data-inclusion and modelling approach to better capture the relationship observed in high-quality registry data between MIR (and implicitly 5-year survival) and health-system access and quality of care.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAdditional sources of uncertainty may not be captured, such as uncertainty for model covariates other than the HIV crude death rate.
“Tenth, additional sources of uncertainty might not be captured, such as for the covariates used in the models with the exception of the HIV crude death rate.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationWHO's Global Health Estimates for cause of death cover 2000-2015 for 183 countries and 176 causes.
“WHO has produced cause of death Global Health Estimates (GHE) at the country level with the most recent spanning from 2000 to 2015 for 183 countries and 176 causes of death.19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe SDGs focus on tracking hepatitis B incidence rather than hepatitis C mortality.
“yet the SDGs are focused on tracking hepatitis B incidence (SDG 3.3.4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites SDG 3.3.4
Not checked in the free run.
May combine two claims.
Study design and conductnone givenVerbal autopsy data sources vary substantially in training and instrument, which may reduce comparability of cause-of-death data between locations.
“Fifth, sources of VA data vary substantially in terms of the training provided and the instrument used in collecting the data, which might reduce the comparability of cause of death data between locations.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataGBD results combine data and estimation; recent-year estimates rely more on modelling, as shown by larger median uncertainty intervals from 2012 to 2016, and the same is true for locations with low data completeness.
“Finally, GBD results are necessarily a combination of data and estimation. Due to lags in reporting, estimates for the most recent years rely more on the modelling process—evidenced by larger median UI by year between 2012 and 2016— as do estimates for locations with low levels of data completeness.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationGarbage code redistribution is vital to GBD 2016 results; the methods could theoretically contribute bias, but no evidence of such bias was identified.
“Sixth, our approach to garbage code redistribution is vital to the results presented in GBD 2016—although our methods of redistribution could theoretically contribute bias, we have identified no evidence of this.3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Wang, 2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenBoth vital registration and verbal autopsy data depend on accurate assignment of underlying cause of death, which is complicated by multimorbidities.
“Second, both VR data and VA data sources depend on how accurately underlying cause of death is assigned and this is complicated by multimorbidities.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe rapid declines in CMNN conditions reflect the global health community's intense focus over recent decades on improving child survival and reducing pregnancy-related risks.
“This is a laudable and welcome reflection of the intense focus of the global health community over the past several decades on improving child survival and reducing pregnancy-related risks.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn rigorous validation tests, verbal autopsy performs well for some causes and poorly for others.
“Nevertheless, these data are still based on VA, which in rigorous validation tests performs well for some causes and not others.63”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Murray, 2011, Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets, Popul Health Metr source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNo standardised empirical approach has been developed for selecting causes to use negative binomial modelling.
“Eighth, while some causes use negative binomial modelling approaches to improve estimation with over-dispersed data, we have not yet developed a standardised empirical approach for selecting causes to use this method.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The GBD cause hierarchy's categories at each level are mutually exclusive and collectively exhaustive.
“The GBD cause list is organised as a hierarchy (appendix 1 p 477), with each level composed of causes of death that are mutually exclusive and collectively exhaustive.”
The paper relies on this without support.
Each death can be assigned to a single underlying cause according to ICD principles.
“For GBD, each death is attributed to a single underlying cause—the cause that initiated the series of events leading to death—in accordance with ICD principles.”
The paper relies on this without support.
Conflict and terrorism are causing reversals in some locations such as Syria and Yemen.
“Other challenges, such as conflict and terrorism, are clearly causing reversals in some locations such as Syria and Yemen.”
The paper relies on this without support.
There is a strong relationship between garbage coding and age.
“Because there is a strong relationship between garbage coding and age, and important demographic shifts are underway, reporting of garbage codes should perhaps in the future be age standardised.”
The paper relies on this without support.
GBD methods generate unbiased estimates even for locations with lower-quality data, and deaths in those locations are not systematically higher or lower than estimated.
“however, even for locations with lower-quality data, our methods support the generation of unbiased estimates and as such we do not expect deaths in these locations to be systematically higher or lower than estimated.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The methods used to generate estimates for GBD 2023 have been extensively peer reviewed over previous rounds of GBD and concurrently as part of the peer review process for GBD 2023.
“These methods have been extensively peer reviewed over previous rounds of GBD14, 15, 16, 17, 18, 19 and concurrently as part of the peer review process for GBD 2023.”
Opioid use disorder is a major public health burden worldwide and is associated with substantial mortality and morbidity.
“Opioid use disorder (OUD) is a major public health burden worldwide and is associated with substantial mortality and morbidity (1, 2).”
From Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Claim of faster CMNN declines at lower SDI conflicts with reported percentages
MajorThe discussion says declines were faster in lower-SDI quintiles, but the reported 1980-2016 declines are smallest in the low-SDI quintile. The low-middle-SDI decline is also smaller than those in the middle- and high-middle-SDI quintiles.
“This transition was characterised by declining rates of CMNN diseases in all SDI quintiles, with faster rates of decline in lower-SDI quintiles.”
“Declines in age-standardised YLL rates for CMNN causes over the 37 years examined ranged from 60·6% (95% UI 58·2–64·7) for high SDI locations, 77·0% (73·4–79·9) for high-middle SDI, 74·1% (72·3–76·0) for middle SDI, 69·0% (66·9–70·9) for low-middle SDI, and 58·5% (55·6–61·0) for low SDI.”
Increase in deaths at ages 90-94 differs tenfold
MinorThe results report a 17·8% increase, but the abstract reports 178% for the same age group and period. The results' uncertainty interval of 176-181% also conflicts with its 17·8% point estimate.
“Shifts at age 90 and older were the most substantial, with a 17·8% (95 UI 176–181) increase in the number of deaths in the 90–94 age group”
“a 178% (95% UI 176–181) increase in deaths in ages 90–94 years”
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070 · see citing works
Self-citationVos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253 · see citing works
Self-citationWang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596 · see citing works
Self-citationGlobal, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Roth, G. A., Johnson, C., Abajobir, A., Abd-Allah, F., Abera, S. F., Abyu, G., Ahmed, M., Aksut, B., Alam, T., Alam, K., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.052 · Cited by 3,791 · see citing works
Self-citationTudor Hart, J. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92410-x · Cited by 3,253 · see citing works
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, U., Battle, K. E., Moyes, C. L., Henry, A., Eckhoff, P. A., et al. (2015) · Nature · doi:10.1038/nature15535 · Cited by 3,225 · see citing works
Self-citationImpact of regional climate change on human health
Patz, J. A., Campbell-Lendrum, D., Holloway, T., & Foley, J. A. (2005) · Nature · doi:10.1038/nature04188 · Cited by 3,103 · see citing works
Whitmee, S., Haines, A., Beyrer, C., Boltz, F., Capon, A. G., de Souza Dias, B. F., Ezeh, A., Frumkin, H., Gong, P., Head, P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60901-1 · Cited by 2,998 · see citing works
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757 · see citing works
Climate change and human health: present and future risks
McMichael, A. J., Woodruff, R. E., & Hales, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68079-3 · Cited by 2,585 · see citing works
Alkema, L., Chou, D., Hogan, D., Zhang, S., Moller, A.-B., Gemmill, A., Fat, D. M., Boerma, T., Temmerman, M., Mathers, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00838-7 · Cited by 2,261 · see citing works
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749 · see citing works
Self-citationMortality and Morbidity in the 21st Century
Case, A., & Deaton, A. (2017) · Brookings Papers on Economic Activity · doi:10.1353/eca.2017.0005 · Cited by 1,448 · see citing works
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444 · see citing works
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people
Shah, A. D., Langenberg, C., Rapsomaniki, E., Denaxas, S., Pujades-Rodriguez, M., Gale, C. P., Deanfield, J., Smeeth, L., Timmis, A., & Hemingway, H. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70219-0 · Cited by 1,225 · see citing works
Global health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220 · see citing works
[Global health 2035: a world converging within a generation].
Jamison, D. T. T., Summers, L. H., Alleyne, G. A. O., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., EVANS, D. B., Feachem, R. G., Frenk, J. M., et al. (2015) · PubMed · Cited by 936 · see citing works
Global status report on violence prevention 2014
Butchart, A., Mikton, C. R., Dahlberg, L. L., & Krug, E. G. (2015) · Injury Prevention · doi:10.1136/injuryprev-2015-041640 · Cited by 832 · see citing works
Wang, H., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Abraha, H. N., Abu-Raddad, L. J., Abu-Rmeileh, N. M. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31833-0 · Cited by 801 · see citing works
Self-citationBarber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., McKee, M., Nolte, E., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30818-8 · Cited by 764 · see citing works
Self-citationGlobal spread of dengue virus types: mapping the 70 year history
Messina, J. P., Brady, O. J., Scott, T. W., Zou, C., Pigott, D. M., Duda, K. A., Bhatt, S., Katzelnick, L., Howes, R. E., Battle, K. E., et al. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2013.12.011 · Cited by 716 · see citing works
Self-citationMortality after the 2003 invasion of Iraq: a cross-sectional cluster sample survey
Burnham, G. M., Lafta, R., Doocy, S., & Roberts, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69491-9 · Cited by 650 · see citing works
The Future of Antibiotics and Resistance
Spellberg, B. J., Bartlett, J. G., & Gilbert, D. N. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1215093 · Cited by 648 · see citing works
Wang, H., Wolock, T. M., Carter, A., Nguyen, G., Kyu, H. H., Gakidou, E. E., Hay, S. I., Mills, E. J., Trickey, A., Msemburi, W., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30087-x · Cited by 613 · see citing works
Self-citationMeasuring The Health Of Nations: Updating An Earlier Analysis
Nolte, E., & McKee, M. (2008) · Health Affairs · doi:10.1377/hlthaff.27.1.58 · Cited by 465 · see citing works
Algorithms for enhancing public health utility of national causes-of-death data
Naghavi, M., Makela, S., Foreman, K., O'Brien, J., Pourmalek, F., & Lozano, R. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-9 · Cited by 440 · see citing works
Self-citationHazardous alcohol drinking and premature mortality in Russia: a population based case-control study
Leon, D. A., Saburova, L., Tomkins, S., Andreev, E., Kiryanov, N., McKee, M., & Shkolnikov, V. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60941-6 · Cited by 438 · see citing works
Rising mortality associated with hepatitis C virus in the United States, 2003–2013
Ly, K. N., Hughes, E. M., Jiles, R. B., & Holmberg, S. D. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw111 · Cited by 358 · see citing works
Golding, N., Burstein, R., Longbottom, J., Browne, A. J., Fullman, N., Osgood-Zimmerman, A. E., Earl, L., Bhatt, S., Cameron, E., Casey, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31758-0 · Cited by 304 · see citing works
Self-citationMeasuring the health of nations: analysis of mortality amenable to health care
Nolte, E., & McKee, M. (2003) · BMJ · doi:10.1136/bmj.327.7424.1129 · Cited by 288 · see citing works
MappingPlasmodium falciparumMortality in Africa between 1990 and 2015
Gething, P. W., Casey, D., Weiss, D. J., Bisanzio, D., Bhatt, S., Cameron, E., Battle, K. E., Dalrymple, U., Rozier, J. A., Rao, P. C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606701 · Cited by 276 · see citing works
Self-citationNeufeld, M., & Rehm, J. T. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags134 · Cited by 246 · see citing works
Self-citationDieleman, J. L., Schneider, M. T., Haakenstad, A., Singh, L., Sadat, N., Birger, M., Reynolds, A., Templin, T., Hamavid, H., Chapin, A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30168-4 · Cited by 234 · see citing works
Ramsey, R., Giskes, K., Turrell, G., & Gallegos, D. (2011) · Public Health Nutrition · doi:10.1017/s1368980011001996 · Cited by 208 · see citing works
Tackling the threat of antimicrobial resistance: from policy to sustainable action
Shallcross, L. J., Howard, S. J., Fowler, T., & Davies, S. C. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0082 · Cited by 197 · see citing works
Murray, C. J., Lopez, A. D., Black, R., Ahuja, R., Ali, S. M., Baqui, A., Dandona, L., Dantzer, E., Das, V., Dhingra, U., et al. (2011) · Population Health Metrics · doi:10.1186/1478-7954-9-27 · Cited by 194 · see citing works
Self-citationVariations in amenable mortality—Trends in 16 high-income nations
Nolte, E., & McKee, M. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.08.002 · Cited by 177 · see citing works
Lozano, R., Lopez, A. D., Atkinson, C., Naghavi, M., Flaxman, A. D., & Murray, C. J. (2011) · Population Health Metrics · doi:10.1186/1478-7954-9-32 · Cited by 101 · see citing works
Self-citationTobacco control progress in low and middle income countries in comparison to high income countries
Anderson, C., Becher, H., & Winkler, V. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13101039 · Cited by 85 · see citing works
Hernández, B., Ramírez-Villalobos, D., Romero, M., Gómez, S., Atkinson, C., & Lozano, R. (2011) · Population Health Metrics · doi:10.1186/1478-7954-9-38 · Cited by 80 · see citing works
Self-citationIraq War mortality estimates: A systematic review
Tapp, C., Burkle, F. M., Wilson, K. R., Takaro, T. K., Guyatt, G. H., Amad, H., & Mills, E. J. (2008) · Conflict and Health · doi:10.1186/1752-1505-2-1 · Cited by 76 · see citing works
Delnord, M., Hindori‐Mohangoo, A., Smith, L., Szamotulska, K., Richards, J., Deb‐Rinker, P., Rouleau, J., Velebil, P., Zile, I., Sakkeus, L., et al. (2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14273 · Cited by 64 · see citing works
Pridemore, W. A., Chamlin, M. B., Kaylen, M. T., & Андреев, Е. М. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12256 · Cited by 52 · see citing works
Estimating mortality using data from civil registration: a cross-sectional study in India
Gupta, M., Rao, C., Lakshmi, P., Prinja, S., & Kumar, R. (2016) · Bulletin of the World Health Organization · doi:10.2471/blt.15.153585 · Cited by 51 · see citing works
Eck, K. (2018) · Oxford University Press eBooks · doi:10.1093/obo/9780199743292-0232 · Cited by 50 · see citing works
Better health intelligence: a new era for civil registration and vital statistics?
López, A. D., & Setel, P. (2015) · BMC Medicine · doi:10.1186/s12916-015-0333-4 · Cited by 49 · see citing works
Measuring the health of nations: analysis of mortality amenable to health care
(2004) · BMJ · doi:10.1136/bmj.328.7438.494-b · Cited by 39 · see citing works
Bollyky, T. J., Templin, T., Andridge, C., & Dieleman, J. L. (2015) · Health Affairs · doi:10.1377/hlthaff.2015.0343 · Cited by 28 · see citing works
Jakovljević, M., Riegler, A., Jovanović, M., Djordjević, N., Patek, K., Lesch, O., & Walter, H. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt011 · Cited by 22 · see citing works
Vaccine assistance to low- and middle-income countries increased to $3.6 billion in 2014
Haakenstad, A., Birger, M., Singh, L., Liu, P., Lim, S., Ng, M., & Dieleman, J. L. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1080 · Cited by 21 · see citing works
A Debate Over Iraqi Death Estimates
Burnham, G. M., & Roberts, L. (2006) · Science · doi:10.1126/science.314.5803.1241b · Cited by 14 · see citing works
Using PMTCT to raise overall health and development
Coovadia, H. M., & Moodley, D. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)00025-4 · Cited by 3 · see citing works
Flagged first, then by citations
2 of the 55 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Dybul, 2012, Reshaping global health, Policy Rev, 173, 3
Cited by
Sorted by citations
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220 · see citing works
Self-citationRoth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600 · see citing works
Self-citation2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485 · see citing works
Self-citationFitzmaurice, C., Allen, C., Barber, R. M., Barregård, L., Bhutta, Z. A., Brenner, H., Dicker, D., Chimed‐Ochir, O., Dandona, R., Dandona, L., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,229 · see citing works
Self-citationAfshin, A., Sur, P. J., Fay, K. A., Cornaby, L., Ferrara, G., Salama, J. S., Mullany, E. C., Abate, K. H., Abbafati, C., Abebe, Z., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30041-8 · Cited by 5,811 · see citing works
Self-citationFeigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644 · see citing works
Self-citationStanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32225-6 · Cited by 4,943 · see citing works
Self-citationKyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,111 · see citing works
Self-citationJohnson, C. O., Nguyen, M., Roth, G. A., Nichols, E. L., Alam, S., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,324 · see citing works
Self-citationForeman, K. J., Marquez, N., Dolgert, A. J., Fukutaki, K. G., Fullman, N., McGaughey, M., Pletcher, M. A., Smith, A. E., Tang, K., Yuan, C.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31694-5 · Cited by 3,048 · see citing works
Self-citationFlaxman, S. R., Bourne, R. R. A., Resnikoff, S., Ackland, P., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., Keeffe, J., Kempen, J. H., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30393-5 · Cited by 3,477 · see citing works
Self-citationEpidemiology of chronic kidney disease: an update 2022
Kovesdy, C. P. (2022) · Kidney International Supplements · doi:10.1016/j.kisu.2021.11.003 · Cited by 2,998 · see citing works
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30295-3 · Cited by 2,816 · see citing works
Self-citationNaghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasian, M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00367-2 · Cited by 2,889 · see citing works
Self-citationNichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412 · see citing works
Self-citationIkuta, K. S., Swetschinski, L. R., Robles Aguilar, G., Sharara, F., Mestrovic, T., Gray, A. P., Davis Weaver, N., Wool, E. E., Han, C., Gershberg Hayoon, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02185-7 · Cited by 2,235 · see citing works
Self-citationHay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32130-x · Cited by 2,083 · see citing works
Self-citationJames, S. L., Theadom, A., Ellenbogen, R. G., Bannick, M. S., Mountjoy-Venning, W. C., Lucchesi, L. R., Abbasi, N., Abdulkader, R. S., Abraha, H. N., Adsuar, J. C., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30415-0 · Cited by 2,019 · see citing works
Self-citationTroeger, C., Blacker, B. F., Khalil, I. A., Rao, P. C., Cao, J., Zimsen, S. R. M., Albertson, S. B., Deshpande, A., Farag, T. H., Zegeye, A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30310-4 · Cited by 1,988 · see citing works
Self-citationFeigin, V. L., Norrving, B., & Mensah, G. A. (2017) · Circulation Research · doi:10.1161/circresaha.116.308413 · Cited by 2,184 · see citing works
Self-citationStatus of Hypertension in China: Results From the China Hypertension Survey, 2012–2015
Wang, Z., Chen, Z., Zhang, L., Wang, X., Hao, G., Zhang, Z., Shao, L., Tian, Y., Dong, Y., Zheng, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032380 · Cited by 1,698 · see citing works
Feigin, V. L., Abate, M. D., Abate, Y. H., ElHafeez, S. A., Abd-Allah, F., Abdelalim, A., Abdelkader, A. F. I., Abdelmasseh, M., Abd-Elsalam, S. M., Abdi, P., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00369-7 · Cited by 2,049 · see citing works
Self-citationDegenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., Whiteford, H., Leung, J., Naghavi, M., Griswold, M., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30337-7 · Cited by 1,572 · see citing works
Self-citationStroke in China: advances and challenges in epidemiology, prevention, and management
Wu, S., Wu, B., Liu, M., Chen, Z., Wang, W., Anderson, C. S., Sandercock, P. A., Wang, Y., Huang, Y., Cui, L., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30500-3 · Cited by 1,593 · see citing works
Self-citationMokdad (2018) · doi:10.1001/jama.2018.0158 · Cited by 1,517 · see citing works
Self-citationGlobal, regional, and country-specific lifetime risks of stroke, 1990 and 2016
Collaborators, T. G. 2. L. R. O. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804492 · Cited by 1,503 · see citing works
Fitzmaurice, C., Akinyemiju, T., Lami, F., Alam, S., Alizadeh‐Navaei, R., Allen, C., Alsharif, U., Alvis‐Guzmán, N., Amini, E., Anderson, B. O., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2706 · Cited by 1,520 · see citing works
Self-citationRossaint, R., Bouillon, B., Černý, V., Coats, T., Duranteau, J., Fernández‐Mondejar, E., Filipescu, D. C., Hunt, B. J., Komadina, R., Nardi, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1265-x · Cited by 1,475 · see citing works
Troeger, C., Blacker, B. F., Khalil, I. A., Rao, P. C., Cao, S., Zimsen, S. R. M., Albertson, S. B., Stanaway, J. D., Deshpande, A., Zegeye, A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30362-1 · Cited by 1,512 · see citing works
Self-citationGlobal Burden of Disease and the Impact of Mental and Addictive Disorders
Rehm, J., & Shield, K. D. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-0997-0 · Cited by 1,388 · see citing works
Epidemiology of cardiovascular disease in China: current features and implications
Zhao, D. H., Liu, J., Wang, M., Zhang, X., & Zhou, M. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0119-4 · Cited by 1,407 · see citing works
Self-citationXie, Y., Bowe, B. C., Mokdad, A. H., Xian, H., Yan, Y., Li, T., Maddukuri, G. S., Tsai, C.-Y., Floyd, T., & Al‐Aly, Z. (2018) · Kidney International · doi:10.1016/j.kint.2018.04.011 · Cited by 1,397 · see citing works
Self-citationSpahn, D. R., Bouillon, B., Černý, V., Duranteau, J., Filipescu, D. C., Hunt, B. J., Komadina, R., Maegele, M., Nardi, G., Riddez, L., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2347-3 · Cited by 1,273 · see citing works
Effects of stress on the development and progression of cardiovascular disease
Kivimäki, M., & Steptoe, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.189 · Cited by 1,197 · see citing works
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,246 · see citing works
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R., & Zhou, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,230 · see citing works
Gender inequality and restrictive gender norms: Framing the challenges to health
Heise, L., Greene, M. E., Opper, N., Stavropoulou, M., Harper, C., Nascimento, M., Zewdie, D., Darmstadt, G. L., Greene, M. E., Hawkes, S., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30652-x · Cited by 1,163 · see citing works
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271 · see citing works
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Moon, A. M., Singal, A. G., & Tapper, E. B. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.060 · Cited by 1,154 · see citing works
Prevalence and Disease Burden of Chronic Kidney Disease
Lv, J., & Zhang, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_1 · Cited by 1,119 · see citing works
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Gomes, M. A. M., Brandão, A. A., Feitosa, A. D. M., Machado, C. A., Poli‐de‐Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,305 · see citing works
Dandona, L., Dandona, R., Kumar, G. A., Shukla, D., Paul, V. K., Balakrishnan, K., Prabhakaran, D., Tandon, N., Salvi, S., Dash, A. P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32804-0 · Cited by 1,062 · see citing works
Self-citationKruk, M. E., Gage, A. D., Joseph, N. T., Danaei, G., García-Saisó, S., & Salomon, J. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31668-4 · Cited by 1,050 · see citing works
Self-citationNaghavi, M. (2019) · BMJ · doi:10.1136/bmj.l94 · Cited by 1,043 · see citing works
Self-citationBeghi, E., Giussani, G., Nichols, E., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Adib, M. G., Agrawal, S., Alahdab, F., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30454-x · Cited by 1,036 · see citing works
Self-citationFullman, N., Yearwood, J., Abay, S. M., Abbafati, C., Abd-Allah, F., Abdela, J., Abdelalim, A., Abebe, Z., Abebo, T. A., Aboyans, V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30994-2 · Cited by 1,013 · see citing works
Self-citationQiu, H., Cao, S., & Xu, R. (2021) · 癌症:英文版 · doi:10.1002/cac2.12197 · Cited by 1,015 · see citing works
Physical activity, exercise, and chronic diseases: A brief review
Anderson, E., & Durstine, J. L. (2019) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2019.08.006 · Cited by 1,071 · see citing works
Calder, P., Carr, A., Gombart, A., & Eggersdorfer, M. (2020) · Nutrients · doi:10.3390/nu12041181 · Cited by 972 · see citing works
Jager, K. J., Kovesdy, C., Langham, R., Rosenberg, M., Jha, V., & Zoccali, C. (2019) · Kidney International · doi:10.1016/j.kint.2019.07.012 · Cited by 957 · see citing works
Self-citationCarotenoids in human nutrition and health.
Eggersdorfer, M., & Wyss, A. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.06.001 · Cited by 812 · see citing works
The global burden of kidney disease and the sustainable development goals
Luyckx, V. A., Tonelli, M. A., & Stanifer, J. W. (2018) · Bulletin of the World Health Organization · doi:10.2471/blt.17.206441 · Cited by 961 · see citing works
Troeger, C., Khalil, I. A., Rao, P. C., Cao, S., Blacker, B. F., Ahmed, T., Armah, G. E., Bines, J. E., Brewer, T. G., Colombara, D. V., et al. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.1960 · Cited by 854 · see citing works
Self-citationA catalog of genetic loci associated with kidney function from analyses of a million individuals
Study, L. C., Wuttke, M., Program, V. A. M. V., Li, Y., Li, M., Sieber, K. B., Feitosa, M. F., Gorski, M., Tin, A., Wang, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0407-x · Cited by 854 · see citing works
Self-citationYuen, M., Chen, D., Dusheiko, G. M., Janssen, H. L. A., Lau, D., LOCARNINI, S. A., Peters, M. G., & Lai, C. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.35 · Cited by 848 · see citing works
Measuring population ageing: an analysis of the Global Burden of Disease Study 2017
Chang, A. Y., Skirbekk, V., Tyrovolas, S., Kassebaum, N. J., & Dieleman, J. L. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30019-2 · Cited by 828 · see citing works
Self-citationWafa, H. A., Wolfe, C. D. A., Emmett, E. S., Roth, G. A., Johnson, C. O., & Wang, Y. (2020) · Stroke · doi:10.1161/strokeaha.120.029606 · Cited by 825 · see citing works
Self-citationChu, D. K., Kim, L. H.-Y., Young, P. J., Zamiri, N., Almenawer, S. A., Jaeschke, R., Szczeklik, W., Schünemann, H. J., Neary, J. D., & Alhazzani, W. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30479-3 · Cited by 778 · see citing works
Epidemiology of cardiovascular disease in Europe
Townsend, N. P., Kazakiewicz, D., Wright, F. L., Timmis, A., Huculeci, R., Torbica, A., Gale, C. P., Achenbach, S. S., Weidinger, F. F., & Vardas, P. E. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00607-3 · Cited by 817 · see citing works
Skin microbiota–host interactions
Chen, Y. E., Fischbach, M. A., & Belkaid, Y. (2018) · Nature · doi:10.1038/nature25177 · Cited by 788 · see citing works
Bekker, L., Alleyne, G. A. O., Baral, S., Cepeda, J., Daskalakis, D., Dowdy, D. W., Dybul, M. R., Eholié, S. P., Esom, K., Garnett, G. P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31070-5 · Cited by 775 · see citing works
Stanaway, J. D., Reiner, R. C., Blacker, B. F., Goldberg, E. M., Khalil, I. A., Troeger, C. E., Andrews, J. R., Bhutta, Z. A., Crump, J. A., Im, J., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30685-6 · Cited by 835 · see citing works
Self-citationBurden of Cardiovascular Diseases in China, 1990-2016
Liu, S., Yichong, L., Zeng, X., Wang, H., Yin, P., Wang, L., Liu, Y., Liu, J., Qi, J., Ran, S., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0295 · Cited by 714 · see citing works
Self-citationKhalil, I. A., Troeger, C., Blacker, B. F., Rao, P. C., Brown, A., Atherly, D., Brewer, T. G., Engmann, C., Houpt, E. R., Kang, G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30475-4 · Cited by 691 · see citing works
Self-citationFan, M., Sun, D., Zhou, T., Heianza, Y., Lv, J., Li, L., & Qi, L. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz849 · Cited by 708 · see citing works
Patel, A. P., Fisher, J. L., Nichols, E. L., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Agius, D., Alahdab, F., Alam, S., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30468-x · Cited by 656 · see citing works
Self-citationGlobal Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016
Cowan, A. J., Allen, C., Barac, A., Basaleem, H., Bensenor, I., Curado, M. P., Foreman, K., Gupta, R., Harvey, J., Hosgood, H. D., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2128 · Cited by 631 · see citing works
Self-citationThe effect of global change on mosquito-borne disease
Franklinos, L. H. V., Jones, K. E., Redding, D. W., & Abubakar, I. I. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30161-6 · Cited by 655 · see citing works
Amini, M., Zayeri, F., & Salehi, M. (2021) · BMC Public Health · doi:10.1186/s12889-021-10429-0 · Cited by 636 · see citing works
Kamangar, F., Nasrollahzadeh, D., Safiri, S., Sepanlou, S. G., Fitzmaurice, C., Ikuta, K. S., Bisignano, C., Islami, F., Roshandel, G., Lim, S. S., et al. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30007-8 · Cited by 648 · see citing works
Self-citationEtemadi, A., Safiri, S., Sepanlou, S. G., Ikuta, K. S., Bisignano, C., Shakeri, R., Amani, M., Fitzmaurice, C., Nixon, M. R., Abbasi, N., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30328-0 · Cited by 634 · see citing works
Self-citationDeuschl, G., Beghi, E., Fazekas, F., Varga, T., Christoforidi, K., Sipido, E., Bassetti, C. L., Vos, T., & Feigin, V. L. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30190-0 · Cited by 633 · see citing works
Self-citationThe COVID-19 pandemic and physical activity
Woods, J. A., Hutchinson, N. T., Powers, S. K., Roberts, W. O., Gómez‐Cabrera, M. C., Radak, Z. O., Berkes, I., Boros, A., Boldogh, I. R., Leeuwenburgh, C., et al. (2020) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2020.05.006 · Cited by 647 · see citing works
Jager, K. J., Kovesdy, C. P., Langham, R. G., Rosenberg, M. E., Jha, V., & Zoccali, C. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz174 · Cited by 643 · see citing works
Self-citationNieuwenhuijsen, M. J. (2020) · Environment International · doi:10.1016/j.envint.2020.105661 · Cited by 621 · see citing works
Global burden of postoperative death
Nepogodiev, D., Martin, J. E., Biccard, B. M., Makupe, A., Bhangu, A. A., Nepogodiev, D., Martin, J. E., Biccard, B. M., Makupe, A., Ademuyiwa, A. O., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33139-8 · Cited by 617 · see citing works
Plana-Ripoll, O., Pedersen, C. B., Agerbo, E., Holtz, Y., Erlangsen, A., Canudas-Romo, V., Andersen, P. K., Charlson, F. J., Christensen, M. K., Erskine, H. E., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32316-5 · Cited by 595 · see citing works
Self-citationTroeger, C., Blacker, B. F., Khalil, I. A., Zimsen, S. R. M., Albertson, S. B., Abate, D., Abdela, J., Adhikari, T. B., Aghayan, S. A., Agrawal, S., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30496-x · Cited by 578 · see citing works
Self-citationICD-11: an international classification of diseases for the twenty-first century
Harrison, J., Weber, S., Jakob, R., & Chute, C. G. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01534-6 · Cited by 575 · see citing works
James, S. L., Lucchesi, L. R., Bisignano, C., Castle, C. D., Dingels, Z. V., Fox, J. T., Hamilton, E. B., Henry, N. J., Krohn, K. J., Liu, Z., et al. (2020) · Injury Prevention · doi:10.1136/injuryprev-2019-043286 · Cited by 571 · see citing works
Self-citationGlobal Disability Burdens of Diabetes-Related Lower-Extremity Complications in 1990 and 2016
Zhang, Y., Lazzarini, P. A., McPhail, S., van Netten, J. J., Armstrong, D. G., & Pacella, R. (2020) · Diabetes Care · doi:10.2337/dc19-1614 · Cited by 594 · see citing works
Self-citationBoerma, T., Requejo, J., Victora, C. G., Amouzou, A., George, A., Agyepong, I., Barroso, C., Barros, A. J. D., Bhutta, Z. A., Black, R. E., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30104-1 · Cited by 517 · see citing works
Self-citationThe Prevalence of Dementia: A Systematic Review and Meta-Analysis
Cao, Q., Tan, C.-C., Xu, W., Hu, H., Cao, X.-P., Dong, Q., Tan, L., & Yu, J.-T. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-191092 · Cited by 446 · see citing works
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab154 · Cited by 565 · see citing works
Self-citationPrabhakaran, D., Jeemon, P., Sharma, M., Roth, G. A., Johnson, C. O., Harikrishnan, S., Gupta, R., Pandian, J. D., Naik, N., Roy, A., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30407-8 · Cited by 542 · see citing works
Self-citationShrine, N. R. G., Guyatt, A. L., Erzurumluoglu, A. M., Jackson, V. E., Hobbs, B. D., Melbourne, C., Batini, C., Fawcett, K. A., Song, K. S., Sakornsakolpat, P., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0321-7 · Cited by 539 · see citing works
Gender equality in science, medicine, and global health: where are we at and why does it matter?
Shannon, G. D., Jansen, M., Williams, K., Cáceres, C. F., Motta, A., Odhiambo, A., Eleveld, A., & Mannell, J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33135-0 · Cited by 554 · see citing works
Dalsgaard, S., Thorsteinsson, E., Trabjerg, B. B., Schullehner, J., Plana-Ripoll, O., Brikell, I., Wimberley, T., Thygesen, M., Madsen, K. B., Timmerman, A., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3523 · Cited by 510 · see citing works
Gheorghe, A., Griffiths, U., Murphy, A., Legido-Quigley, H., Lamptey, P., & Perel, P. (2018) · BMC Public Health · doi:10.1186/s12889-018-5806-x · Cited by 456 · see citing works
Roth, D. E., Abrams, S. A., Aloia, J. F., Bergeron, G., Bourassa, M. W., Brown, K. H., Calvo, M. S., Cashman, K. D., Combs, G. F., De‐Regil, L. M., et al. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13968 · Cited by 528 · see citing works
Naghavi, M., Kyu, H. H., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abafita, B. J., Abaraogu, U. O., Abbafati, C., Abbasi, M., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01917-8 · Cited by 595 · see citing works
Self-citationTandon, N., Anjana, R. M., Mohan, V., Kaur, T., Afshin, A., Ong, S. K., Mukhopadhyay, S., Thomas, N., Bhatia, E., Krishnan, A., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30387-5 · Cited by 526 · see citing works
Self-citationPu, L., Wang, L., Zhang, R., Zhao, T., Jiang, Y., & Han, L. (2023) · Stroke · doi:10.1161/strokeaha.122.040073 · Cited by 525 · see citing works
Registration of systematic reviews in PROSPERO: 30,000 records and counting
Page, M. J., Shamseer, L., & Tricco, A. C. (2018) · Systematic Reviews · doi:10.1186/s13643-018-0699-4 · Cited by 509 · see citing works
Dhillon, P. K., Mathur, P., Nandakumar, A., Fitzmaurice, C., Kumar, G. A., Mehrotra, R., Shukla, D., Rath, G. K., Gupta, P. C., Swaminathan, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30447-9 · Cited by 504 · see citing works
Self-citationKhalil, I. A., Troeger, C., Rao, P. C., Blacker, B. F., Brown, A., Brewer, T. G., Colombara, D. V., de Hostos, E. L., Engmann, C., Guerrant, R. L., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30283-3 · Cited by 479 · see citing works
Self-citationMurray, C. J. L., Callender, C. S. K. H., Kulikoff, X. R., Srinivasan, V., Abate, D., Abate, K. H., Abay, S. M., Abbasi, N., Abbastabar, H., Abdela, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32278-5 · Cited by 505 · see citing works
Self-citationGao, K., Cao, L.-F., Ma, W.-Z., Gao, Y.-J., Luo, M.-S., Zhu, J., Li, T., & Zhou, D. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101264 · Cited by 482 · see citing works
Elliott, J., Bodinier, B., Bond, T. A., Chadeau‐Hyam, M., Εvangelou, Ε., Moons, K. G. M., Dehghan, A., Muller, D. C., Elliott, P., & Tzoulaki, I. (2020) · JAMA · doi:10.1001/jama.2019.22241 · Cited by 471 · see citing works
Epidemiological Features of Cardiovascular Disease in Asia
Zhao, D. H. (2021) · JACC Asia · doi:10.1016/j.jacasi.2021.04.007 · Cited by 495 · see citing works
- Authors
- Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., Ahmadi, A., Ahmed, M. B., Aichour, A. N., Aichour, M. T. E., Aichour, I., Aiyar, S., Alahdab, F., Al-Aly, Z., Alam, K., Alam, N., Alam, T., Alene, K. A., Al-Eyadhy, A., Ali, S. D., Alizadeh-Navaei, R., Alkaabi, J. M., Alkerwi, A., Alla, F., Allebeck, P., Allen, C., Al-Raddadi, R., Alsharif, U., Altirkawi, K. A., Alvis-Guzman, N., Amare, A. T., Amini, E., Ammar, W., Amoako, Y. A., Anber, N., Andersen, H. H., Andrei, C. L., Androudi, S., Ansari, H., Antonio, C. A. T., Anwari, P., Ärnlöv, J., Arora, M., Artaman, A., Aryal, K. K., Asayesh, H., Asgedom, S. W., Atey, T. M., Avila-Burgos, L., Avokpaho, E. F. G., Awasthi, A., Babalola, T. K., Bacha, U., Balakrishnan, K., Barac, A., Barboza, M. A., Barker-Collo, S. L., Barquera, S., Barregard, L., Barrero, L. H., Baune, B. T., Bedi, N., Beghi, E., Béjot, Y., Bekele, B. B., Bell, M. L., Bennett, J. R., Bensenor, I. M., Berhane, A., Bernabé, E., Betsu, B. D., Beuran, M., Bhatt, S., Biadgilign, S., Bienhoff, K., Bikbov, B., Bisanzio, D., Bourne, R. R. A., Breitborde, N. J. K., Bulto, L. N. B., Bumgarner, B. R., Butt, Z. A., Cahuana-Hurtado, L., Cameron, E., Campuzano, J. C., Car, J., Cárdenas, R., Carrero, J. J., Carter, A., Casey, D. C., Castañeda-Orjuela, C. A., Catalá-López, F., Charlson, F. J., Chibueze, C. E., Chimed-Ochir, O., Chisumpa, V. H., Chitheer, A. A., Christopher, D. J., Ciobanu, L. G., Cirillo, M., Cohen, A. J., Colombara, D., Cooper, C., Cowie, B. C., Criqui, M. H., Dandona, L., Dandona, R., Dargan, P. I., das Neves, J., Davitoiu, D. V., Davletov, K., de Courten, B., Defo, B. K., Degenhardt, L., Deiparine, S., Deribe, K., Deribew, A., Dey, S., Dicker, D., Ding, E. L., Djalalinia, S., Do, H. P., Doku, D. T., Douwes-Schultz, D., Driscoll, T. R., Dubey, M., Duncan, B. B., Echko, M., El-Khatib, Z. Z., Ellingsen, C. L., Enayati, A., Ermakov, S. P., Erskine, H. E., Eskandarieh, S., Esteghamati, A., Estep, K., Farinha, C. S. E. S., Faro, A., Farzadfar, F., Feigin, V. L., Fereshtehnejad, S.-M., Fernandes, J. C., Ferrari, A. J., Feyissa, T. R., Filip, I., Finegold, S., Fischer, F., Fitzmaurice, C., Flaxman, A. D., Foigt, N., Frank, T., Fraser, M., Fullman, N., Fürst, T., Furtado, J. M., Gakidou, E., Garcia-Basteiro, A. L., Gebre, T., Gebregergs, G. B., Gebrehiwot, T. T., Gebremichael, D. Y., Geleijnse, J. M., Genova-Maleras, R., Gesesew, H. A., Gething, P. W., Gillum, R. F., Giref, A. Z., Giroud, M., Giussani, G., Godwin, W. W., Gold, A. L., Goldberg, E. M., Gona, P. N., Gopalani, S. V., Gouda, H. N., Goulart, A. C., Griswold, M., Gupta, R., Gupta, T., Gupta, V., Gupta, P. C., Haagsma, J. A., Hafezi-Nejad, N., Hailu, A. D., Hailu, G. B., Hamadeh, R. R., Hambisa, M. T., Hamidi, S., Hammami, M., Hancock, J., Handal, A. J., Hankey, G. J., Hao, Y., Harb, H. L., Hareri, H. A., Hassanvand, M. S., Havmoeller, R., Hay, S. I., He, F., Hedayati, M. T., Henry, N. J., Heredia-Pi, I. B., Herteliu, C., Hoek, H. W., Horino, M., Horita, N., Hosgood, H. D., Hostiuc, S., Hotez, P. J., Hoy, D. G., Huynh, C., Iburg, K. M., Ikeda, C., Ileanu, B. V., Irenso, A. A., Irvine, C. M. S., Islam, S. M. S., Jacobsen, K. H., Jahanmehr, N., Jakovljevic, M. B., Javanbakht, M., Jayaraman, S. P., Jeemon, P., Jha, V., John, D., Johnson, C. O., Johnson, S. C., Jonas, J. B., Jürisson, M., Kabir, Z., Kadel, R., Kahsay, A., Kamal, R., Karch, A., Karimi, S. M., Karimkhani, C., Kasaeian, A., Kassaw, N. A., Kassebaum, N. J., Katikireddi, S. V., Kawakami, N., Keiyoro, P. N., Kemmer, L., Kesavachandran, C. N., Khader, Y. S., Khan, E. A., Khang, Y.-H., Khoja, A. T. A., Khosravi, M. H., Khosravi, A., Khubchandani, J., Kiadaliri, A. A., Kieling, C., Kievlan, D., Kim, Y. J., Kim, D., Kimokoti, R. W., Kinfu, Y., Kissoon, N., Kivimaki, M., Knudsen, A. K., Kopec, J. A., Kosen, S., Koul, P. A., Koyanagi, A., Kulikoff, X. R., Kumar, G. A., Kumar, P., Kutz, M., Kyu, H. H., Lal, D. K., Lalloo, R., Lambert, T. L. N., Lan, Q., Lansingh, V. C., Larsson, A., Lee, P. H., Leigh, J., Leung, J., Levi, M., Li, Y., Li Kappe, D., Liang, X., Liben, M. L., Lim, S. S., Liu, P. Y., Liu, A., Liu, Y., Lodha, R., Logroscino, G., Lorkowski, S., Lotufo, P. A., Lozano, R., Lucas, T. C. D., Ma, S., Macarayan, E. R. K., Maddison, E. R., Magdy Abd El Razek, M., Majdan, M., Majdzadeh, R., Majeed, A., Malekzadeh, R., Malhotra, R., Malta, D. C., Manguerra, H., Manyazewal, T., Mapoma, C. C., Marczak, L. B., Markos, D., Martinez-Raga, J., Martins-Melo, F. R., Martopullo, I., McAlinden, C., McGaughey, M., McGrath, J. J., Mehata, S., Meier, T., Meles, K. G., Memiah, P., Memish, Z. A., Mengesha, M. M., Mengistu, D. T., Menota, B. G., Mensah, G. A., Meretoja, T. J., Meretoja, A., Millear, A., Miller, T. R., Minnig, S., Mirarefin, M., Mirrakhimov, E. M., Misganaw, A., Mishra, S. R., Mohamed, I. A., Mohammad, K. A., Mohammadi, A., Mohammed, S., Mokdad, A. H., Mola, G. L. D., Mollenkopf, S. K., Molokhia, M., Monasta, L., Montañez, J. C., Montico, M., Mooney, M. D., Moradi-Lakeh, M., Moraga, P., Morawska, L., Morozoff, C., Morrison, S. D., Mountjoy-Venning, C., Mruts, K. B., Muller, K., Murthy, G. V. S., Musa, K. I., Nachega, J. B., Naheed, A., Naldi, L., Nangia, V., Nascimento, B. R., Nasher, J. T., Natarajan, G., Negoi, I., Ngunjiri, J. W., Nguyen, C. T., Nguyen, Q. L., Nguyen, T. H., Nguyen, G., Nguyen, M., Nichols, E., Ningrum, D. N. A., Nong, V. M., Noubiap, J. J. N., Ogbo, F. A., Oh, I.-H., Okoro, A., Olagunju, A. T., Olsen, H. E., Olusanya, B. O., Olusanya, J. O., Ong, K., Opio, J. N., Oren, E., Ortiz, A., Osman, M., Ota, E., PA, M., Pacella, R. E., Pakhale, S., Pana, A., Panda, B. K., Panda-Jonas, S., Papachristou, C., Park, E.-K., Patten, S. B., Patton, G. C., Paudel, D., Paulson, K., Pereira, D. M., Perez-Ruiz, F., Perico, N., Pervaiz, A., Petzold, M., Phillips, M. R., Pigott, D. M., Pinho, C., Plass, D., Pletcher, M. A., Polinder, S., Postma, M. J., Pourmalek, F., Purcell, C., Qorbani, M., Quintanilla, B. P. A., Radfar, A., Rafay, A., Rahimi-Movaghar, V., Rahman, M. H. U., Rahman, M., Rai, R. K., Ranabhat, C. L., Rankin, Z., Rao, P. C., Rath, G. K., Rawaf, S., Ray, S. E., Rehm, J., Reiner, R. C., Reitsma, M. B., Remuzzi, G., Rezaei, S., Rezai, M. S., Rokni, M. B., Ronfani, L., Roshandel, G., Roth, G. A., Rothenbacher, D., Ruhago, G. M., SA, R., Saadat, S., Sachdev, P. S., Sadat, N., Safdarian, M., Safi, S., Safiri, S., Sagar, R., Sahathevan, R., Salama, J., Salamati, P., Salomon, J. A., Samy, A. M., Sanabria, J. R., Sanchez-Niño, M. D., Santomauro, D., Santos, I. S., Santric Milicevic, M. M., Sartorius, B., Satpathy, M., Schmidt, M. I., Schneider, I. J. C., Schulhofer-Wohl, S., Schutte, A. E., Schwebel, D. C., Schwendicke, F., Sepanlou, S. G., Servan-Mori, E. E., Shackelford, K. A., Shahraz, S., Shaikh, M. A., Shamsipour, M., Shamsizadeh, M., Sharma, J., Sharma, R., She, J., Sheikhbahaei, S., Shey, M., Shi, P., Shields, C., Shigematsu, M., Shiri, R., Shirude, S., Shiue, I., Shoman, H., Shrime, M. G., Sigfusdottir, I. D., Silpakit, N., Silva, J. P., Singh, J. A., Singh, A., Skiadaresi, E., Sligar, A., Smith, D. L., Smith, A., Smith, M., Sobaih, B. H. A., Soneji, S., Sorensen, R. J. D., Soriano, J. B., Sreeramareddy, C. T., Srinivasan, V., Stanaway, J. D., Stathopoulou, V., Steel, N., Stein, D. J., Steiner, C., Steinke, S., Stokes, M. A., Strong, M., Strub, B., Subart, M., Sufiyan, M. B., Sunguya, B. F., Sur, P. J., Swaminathan, S., Sykes, B. L., Tabarés-Seisdedos, R., Tadakamadla, S. K., Takahashi, K., Takala, J. S., Talongwa, R. T., Tarawneh, M. R., Tavakkoli, M., Taveira, N., Tegegne, T. K., Tehrani-Banihashemi, A., Temsah, M.-H., Terkawi, A. S., Thakur, J. S., Thamsuwan, O., Thankappan, K. R., Thomas, K. E., Thompson, A. H., Thomson, A. J., Thrift, A. G., Tobe-Gai, R., Topor-Madry, R., Torre, A., Tortajada, M., Towbin, J. A., Tran, B. X., Troeger, C., Truelsen, T., Tsoi, D., Tuzcu, E. M., Tyrovolas, S., Ukwaja, K. N., Undurraga, E. A., Updike, R., Uthman, O. A., Uzochukwu, B. S. C., van Boven, J. F. M., Vasankari, T., Venketasubramanian, N., Violante, F. S., Vlassov, V. V., Vollset, S. E., Vos, T., Wakayo, T., Wallin, M. T., Wang, Y.-P., Weiderpass, E., Weintraub, R. G., Weiss, D. J., Werdecker, A., Westerman, R., Whetter, B., Whiteford, H. A., Wijeratne, T., Wiysonge, C. S., Woldeyes, B. G., Wolfe, C. D. A., Woodbrook, R., Workicho, A., Xavier, D., Xiao, Q., Xu, G., Yaghoubi, M., Yakob, B., Yano, Y., Yaseri, M., Yimam, H. H., Yonemoto, N., Yoon, S.-J., Yotebieng, M., Younis, M. Z., Zaidi, Z., Zaki, M. E. S., Zegeye, E. A., Zenebe, Z. M., Zerfu, T. A., Zhang, A. L., Zhang, X., Zipkin, B., Zodpey, S., Lopez, A. D., & Murray, C. J. L.
- ORCID
- Naghavi, Mohsen
- Abajobir, Amanuel Alemu
- Abbafati, Cristiana
- Abbas, Kaja M
- Abd-Allah, Foad
- Abera, Semaw Ferede
- Aboyans, Victor
- Adetokunboh, Olatunji
- Afshin, Ashkan
- Agrawal, Anurag
- Ahmed, Muktar Beshir
- Alahdab, Fares
- Alam, Khurshid
- Alam, Noore
- Alene, Kefyalew Addis
- Al-Eyadhy, Ayman
- Ali, Syed Danish
- Alkaabi, Juma M
- Alkerwi, Ala'a
- Alla, François
- Al-Raddadi, Rajaa
- Alsharif, Ubai
- Altirkawi, Khalid A
- Amare, Azmeraw T
- Amini, Erfan
- Ammar, Walid
- Amoako, Yaw Ampem
- Anber, Nahla
- Androudi, Sofia
- Ansari, Hossein
- Antonio, Carl Abelardo T
- Anwari, Palwasha
- Ärnlöv, Johan
- Arora, Megha
- Asayesh, Hamid
- Asgedom, Solomon W
- Atey, Tesfay Mehari
- Avokpaho, Euripide Frinel G
- Awasthi, Ashish
- Babalola, Tesleem Kayode
- Balakrishnan, Kalpana
- Barac, Aleksandra
- Barboza, Miguel A
- Barker-Collo, Suzanne L
- Barrero, Lope H
- Bedi, Neeraj
- Beghi, Ettore
- Béjot, Yannick
- Bekele, Bayu Begashaw
- Bell, Michelle L
- Berhane, Adugnaw
- Bernabé, Eduardo
- Betsu, Balem Demtsu
- Beuran, Mircea
- Bhatt, Samir
- Biadgilign, Sibhatu
- Bienhoff, Kelly
- Bikbov, Boris
- Bisanzio, Donal
- Bourne, Rupert R A
- Breitborde, Nicholas J K
- Bulto, Lemma Negesa Bulto
- Butt, Zahid A
- Cahuana-Hurtado, Lucero
- Cameron, Ewan
- Car, Josip
- Cárdenas, Rosario
- Carter, Austin
- Castañeda-Orjuela, Carlos A
- Catalá-López, Ferrán
- Charlson, Fiona J
- Chibueze, Chioma Ezinne
- Chisumpa, Vesper Hichilombwe
- Chitheer, Abdulaal A
- Christopher, Devasahayam Jesudas
- Ciobanu, Liliana G
- Cohen, Aaron J
- Colombara, Danny
- Cooper, Cyrus
- Criqui, Michael H
- Dandona, Lalit
- Dandona, Rakhi
- Dargan, Paul I
- Davletov, Kairat
- Degenhardt, Louisa
- Deiparine, Selina
- Deribe, Kebede
- Deribew, Amare
- Dey, Subhojit
- Ding, Eric L
- Djalalinia, Shirin
- Do, Huyen Phuc
- Doku, David Teye
- Driscoll, Tim R
- Dubey, Manisha
- Duncan, Bruce Bartholow
- Ellingsen, Christian Lycke
- Enayati, Ahmadali
- Erskine, Holly E
- Eskandarieh, Sharareh
- Esteghamati, Alireza
- Faro, André
- Farzadfar, Farshad
- Feigin, Valery L
- Fereshtehnejad, Seyed-Mohammad
- Fernandes, João C
- Ferrari, Alize J
- Feyissa, Tesfaye Regassa
- Filip, Irina
- Fischer, Florian
- Fitzmaurice, Christina
- Flaxman, Abraham D
- Foigt, Nataliya
- Frank, Tahvi
- Fullman, Nancy
- Fürst, Thomas
- Gakidou, Emmanuela
- Gebre, Teshome
- Gebregergs, Gebremedhin Berhe
- Gebrehiwot, Tsegaye Tewelde
- Geleijnse, Johanna M
- Gesesew, Hailay Abrha
- Gething, Peter W
- Giroud, Maurice
- Giussani, Giorgia
- Goldberg, Ellen M
- Gona, Philimon N
- Gopalani, Sameer Vali
- Gouda, Hebe N
- Goulart, Alessandra Carvalho
- Griswold, Max
- Gupta, Vipin
- Haagsma, Juanita A
- Hailu, Alemayehu Desalegne
- Hamadeh, Randah Ribhi
- Hambisa, Mitiku Teshome
- Hamidi, Samer
- Hancock, Jamie
- Handal, Alexis J
- Hankey, Graeme J
- Hao, Yuantao
- Harb, Hilda L
- Hassanvand, Mohammad Sadegh
- Hay, Simon I
- He, Fei
- Hedayati, Mohammad T
- Henry, Nathaniel J
- Heredia-Pi, Ileana Beatriz
- Hoek, Hans W
- Horino, Masako
- Horita, Nobuyuki
- Hostiuc, Sorin
- Hotez, Peter J
- Iburg, Kim Moesgaard
- Ileanu, Bogdan Vasile
- Irenso, Asnake Ararsa
- Irvine, Caleb Mackay Salpeter
- Islam, Sheikh Mohammed Shariful
- Jacobsen, Kathryn H
- Jahanmehr, Nader
- Javanbakht, Mehdi
- Jayaraman, Sudha P
- Jeemon, Panniyammakal
- Jha, Vivekanand
- John, Denny
- Johnson, Sarah Charlotte
- Jonas, Jost B
- Jürisson, Mikk
- Kabir, Zubair
- Kadel, Rajendra
- Kahsay, Amaha
- Kamal, Ritul
- Karch, André
- Kasaeian, Amir
- Kassaw, Nigussie Assefa
- Kassebaum, Nicholas J
- Katikireddi, Srinivasa Vittal
- Kawakami, Norito
- Kemmer, Laura
- Khader, Yousef Saleh
- Khan, Ejaz Ahmad
- Khang, Young-Ho
- Khoja, Abdullah Tawfih Abdullah
- Khosravi, Mohammad Hossein
- Khosravi, Ardeshir
- Khubchandani, Jagdish
- Kieling, Christian
- Kim, Yun Jin
- Kim, Daniel
- Kimokoti, Ruth W
- Kinfu, Yohannes
- Kissoon, Niranjan
- Knudsen, Ann Kristin
- Kopec, Jacek A
- Kosen, Soewarta
- Koul, Parvaiz A
- Koyanagi, Ai
- Kulikoff, Xie Rachel
- Kumar, G Anil
- Kumar, Pushpendra
- Kyu, Hmwe H
- Lalloo, Ratilal
- Lansingh, Van C
- Lee, Paul H
- Leigh, James
- Leung, Janni
- Levi, Miriam
- Li, Yongmei
- Liang, Xiaofeng
- Liben, Misgan Legesse
- Lim, Stephen S
- Liu, Patrick Y
- Liu, Angela
- Liu, Yang
- Logroscino, Giancarlo
- Lotufo, Paulo A
- Lozano, Rafael
- Ma, Stefan
- Macarayan, Erlyn Rachelle King
- Maddison, Emilie R
- Majdzadeh, Reza
- Majeed, Azeem
- Malekzadeh, Reza
- Malhotra, Rajesh
- Manyazewal, Tsegahun
- Mapoma, Chabila C
- Marczak, Laurie B
- Martopullo, Ira
- McAlinden, Colm
- McGrath, John J
- Mehata, Suresh
- Meier, Toni
- Meles, Kidanu Gebremariam
- Memiah, Peter
- Memish, Ziad A
- Mengesha, Melkamu Merid
- Mengistu, Desalegn Tadese
- Mensah, George A
- Meretoja, Tuomo J
- Meretoja, Atte
- Miller, Ted R
- Mirrakhimov, Erkin M
- Misganaw, Awoke
- Mishra, Shiva Raj
- Mohammad, Karzan Abdulmuhsin
- Mohammadi, Alireza
- Mohammed, Shafiu
- Mokdad, Ali H
- Mola, Glen Liddell D
- Molokhia, Mariam
- Monasta, Lorenzo
- Montico, Marcella
- Mooney, Meghan D
- Moraga, Paula
- Morozoff, Chloe
- Morrison, Shane D
- Murthy, Gudlavalleti Venkata Satyanarayana
- Musa, Kamarul Imran
- Nachega, Jean B
- Naheed, Aliya
- Naldi, Luigi
- Nascimento, Bruno Ramos
- Nasher, Jamal T
- Nguyen, Cuong Tat
- Nguyen, Quyen Le
- Nguyen, Trang Huyen
- Nichols, Emma
- Ningrum, Dina Nur Anggraini
- Nong, Vuong Minh
- Noubiap, Jean Jacques N
- Ogbo, Felix Akpojene
- Oh, In-Hwan
- Olagunju, Andrew Toyin
- Olsen, Helen E
- Olusanya, Bolajoko Olubukunola
- Olusanya, Jacob Olusegun
- Opio, John Nelson
- Oren, Eyal
- Osman, Majdi
- Ota, Erika
- Pacella, Rosana E
- Pakhale, Smita
- Panda, Basant Kumar
- Park, Eun-Kee
- Patten, Scott B
- Patton, George C
- Paudel, Deepak
- Paulson, Katherine
- Pereira, David M
- Perico, Norberto
- Petzold, Max
- Pigott, David M
- Plass, Dietrich
- Postma, Maarten J
- Pourmalek, Farshad
- Purcell, Caroline
- Qorbani, Mostafa
- Quintanilla, Beatriz Paulina Ayala
- Radfar, Amir
- Rahman, Mohammad Hifz Ur
- Ranabhat, Chhabi Lal
- Rawaf, Salman
- Ray, Sarah E
- Rehm, Jürgen
- Reiner, Robert C
- Reitsma, Marissa B
- Remuzzi, Giuseppe
- Rezaei, Satar
- Rezai, Mohammad Sadegh
- Rokni, Mohammad Bagher
- Ronfani, Luca
- Roshandel, Gholamreza
- Roth, Gregory A
- Rothenbacher, Dietrich
- Ruhago, George Mugambage
- Saadat, Soheil
- Sachdev, Perminder S
- Safdarian, Mahdi
- Safi, Sare
- Safiri, Saeid
- Sagar, Rajesh
- Sahathevan, Ramesh
- Salama, Joseph
- Salomon, Joshua A
- Samy, Abdallah M
- Sanabria, Juan Ramon
- Santomauro, Damian
- Santos, Itamar S
- Sartorius, Benn
- Satpathy, Maheswar
- Schneider, Ione J C
- Schutte, Aletta E
- Schwebel, David C
- Schwendicke, Falk
- Sepanlou, Sadaf G
- Servan-Mori, Edson E
- Shamsipour, Mansour
- Shamsizadeh, Morteza
- Sharma, Jayendra
- Sharma, Rajesh
- She, Jun
- Sheikhbahaei, Sara
- Shey, Muki
- Shields, Chloe
- Shiri, Rahman
- Shiue, Ivy
- Shoman, Haitham
- Shrime, Mark G
- Silva, João Pedro
- Singh, Jasvinder A
- Singh, Abhishek
- Smith, David L
- Smith, Alison
- Sorensen, Reed J D
- Soriano, Joan B
- Sreeramareddy, Chandrashekhar T
- Srinivasan, Vinay
- Stanaway, Jeffrey D
- Steel, Nicholas
- Stein, Dan J
- Stokes, Mark Andrew
- Strong, Mark
- Sunguya, Bruno F
- Sur, Patrick J
- Swaminathan, Soumya
- Sykes, Bryan L
- Tadakamadla, Santosh Kumar
- Takahashi, Ken
- Takala, Jukka S
- Tavakkoli, Mohammad
- Taveira, Nuno
- Tegegne, Teketo Kassaw
- Temsah, Mohamad-Hani
- Terkawi, Abdullah Sulieman
- Thakur, J S
- Thamsuwan, Ornwipa
- Thankappan, Kavumpurathu Raman
- Thrift, Amanda G
- Tran, Bach Xuan
- Tuzcu, Emin Murat
- Tyrovolas, Stefanos
- Ukwaja, Kingsley N
- Undurraga, Eduardo A
- Uthman, Olalekan A
- Uzochukwu, Benjamin S Chudi
- Vasankari, Tommi
- Venketasubramanian, Narayanaswamy
- Violante, Francesco S
- Vos, Theo
- Wallin, Mitchell T
- Wang, Yuan-Pang
- Weiderpass, Elisabete
- Weiss, Daniel J
- Werdecker, Andrea
- Westerman, Ronny
- Whiteford, Harvey A
- Wijeratne, Tissa
- Wiysonge, Charles Shey
- Wolfe, Charles D A
- Woodbrook, Rachel
- Workicho, Abdulhalik
- Xavier, Denis
- Xu, Gelin
- Yaghoubi, Mohsen
- Yakob, Bereket
- Yano, Yuichiro
- Yaseri, Mehdi
- Yonemoto, Naohiro
- Yoon, Seok-Jun
- Yotebieng, Marcel
- Younis, Mustafa Z
- Zaidi, Zoubida
- Zaki, Maysaa El Sayed
- Zegeye, Elias Asfaw
- Zerfu, Taddese Alemu
- Zhang, Anthony Lin
- Zhang, Xueying
- Zodpey, Sanjay
- Murray, Christopher J L
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 390
- Issue
- 10100
- Pages
- 1151-1210
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC5605883
- OpenAlex
- W2753051611
- Semantic Scholar
- 669e743f89ba85e21ac5bf425e09e4719a0fc79d
- Cited by
- 4,821
- References
- 55
- Citations by year
- 2026: 143 · 2025: 300 · 2024: 443 · 2023: 505 · 2022: 576 · 2021: 762 · 2020: 811 · 2019: 702 · 2018: 535 · 2017: 30 · 2016: 4
- FWCI
- 1469.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Lancet (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- Monash University Research Portal (Monash University) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- London School of Economics and Political Science Research Online (London School of Economics and Political Science) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
- Research Open (London South Bank University) (acceptedVersion, cc-by-nc-nd)
- UA Campus Repository (The University of Arizona) (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Anglia Ruskin Research Online (Anglia Ruskin University) (submittedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
- Murdoch University Research Portal (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- RMIT Research Repository (RMIT University Library) (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Own your potential (DEAKIN) (submittedVersion)
- edoc (University of Basel) (submittedVersion)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- eSpace (Curtin University) (submittedVersion)
- Espace ÉTS (ETS) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Opin vísindi (Opin vísindi) (submittedVersion, cc-by)
- Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
- PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion)
- PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion, cc-by)
- Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- CEU Repositorio Institucional (Fundación Universitaria San Pablo CEU) (submittedVersion, cc-by-nc-nd)
- Griffith Research Online (submittedVersion, cc-by)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Tampere University Institutional Repository (Tampere University) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (201-900/Z/16/Z, 201900)
- National Institute for Health and Care Research (NF-SI-0508-10082, NF-SI-0513-10085)
- Medical Research Council (MR/K013351/1, MC_UU_12017/13, MC_UU_12017/15, MR/K00669X/1, MC_UU_12011/2, MC_UU_12011/1)
- National Institute on Aging (P30AG047845)
- National Heart, Lung, and Blood Institute (T32HL007820)
- National Institute of Mental Health (R01MH110163)
- National Institute of Allergy and Infectious Diseases (U01AI096299)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD087993)
- Topics
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Health Sciences › Health Professions › Health Information Management › Global Health and Epidemiology
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Keywords
- cause-specific mortality, premature mortality, years of life lost, age and sex differences, global burden of disease, verbal autopsy, civil registration, data quality assessment, socio-demographic index, non-communicable diseases, infectious diseases, maternal mortality, epidemiological transition, cause of death classification, mortality trends, life expectancy
- MeSH terms
- Global Burden of Disease, Noncommunicable Diseases, Adolescent, Adult, Aged, Aged, 80 and over, Cause of Death, Child, Child, Preschool, Communicable Diseases, Disasters, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Nutrition Disorders, Pregnancy, Pregnancy Complications, Socioeconomic Factors, Global Health, Wounds and Injuries, Age Distribution, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-04.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-04.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review